{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:09:23Z","timestamp":1794265763301,"version":"4.9.0"},"reference-count":559,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["RA 2717\/2-3"],"award-info":[{"award-number":["RA 2717\/2-3"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cellular protein homeostasis, or proteostasis, underpins the integrity, adaptability, and survival of all cells by balancing protein synthesis, folding, trafficking, and degradation. This multilayered network is sustained by coordinated actions of molecular chaperones, the ubiquitin\u2012proteasome system, autophagy-lysosomal pathways, and organelle-specific quality control programs. When this equilibrium collapses, misfolded, aggregated, or damaged proteins accumulate, driving organelle dysfunction, maladaptive stress signaling, and disease progression. Disruption of proteostasis is now recognized as a unifying pathological hallmark linking neurodegenerative disorders, cancer, cardiovascular and metabolic diseases, and autoimmune conditions. This is particularly consequential in post-mitotic organs such as the heart and brain, which possess limited regenerative capacity and are exceptionally vulnerable to proteotoxic stress. Rapid advances now reveal proteostasis as a multicomponent, cross-compartmental, and dynamically adaptable system, rather than isolated pathways. We frame this complexity through the concept of proteostasis resilience, defined as the ability of cells and tissues to maintain proteome stability under stress, and use it to unify disease mechanisms with therapeutic opportunity. This review integrates mechanistic insights with translational advances, outlining how dysregulation of chaperones, autophagy-mitophagy, the ubiquitin\u2012proteasome system, and ER stress pathways drive human diseases, while highlighting emerging therapeutic platforms, from pharmacological chaperones and autophagy modulators to targeted protein degradation technologies, CRISPR screens, spatial biology, and AI-guided drug discovery. Together, this systems-level perspective positions proteostasis resilience as a foundational paradigm for understanding disease vulnerability and designing precision proteostasis-based therapies.<\/jats:p>","DOI":"10.1038\/s41392-026-02714-4","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T23:02:28Z","timestamp":1780959748000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Emerging perspectives in proteostasis: bridging mechanisms and therapeutics for human diseases"],"prefix":"10.1038","volume":"11","author":[{"given":"Ankush","family":"Borlepawar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Neu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3886-2972","authenticated-orcid":false,"given":"Anushka","family":"Deshpande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"B\u00fchringer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvana","family":"Hajieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Frey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2630-9754","authenticated-orcid":false,"given":"Ashraf Yusuf","family":"Rangrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"key":"2714_CR1","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/nrcardio.2017.89","volume":"14","author":"RH Henning","year":"2017","unstructured":"Henning, R. H. & Brundel, B. J. J. M. Proteostasis in cardiac health and disease. Nat. Rev. Cardiol. 14, 637\u2013653 (2017).","journal-title":"Nat. Rev. Cardiol."},{"key":"2714_CR2","doi-asserted-by":"crossref","unstructured":"Schoenheimer, R. The dynamic state of body constituents. JAMA. 120, 654 (1942).","DOI":"10.1001\/jama.1942.02830430076032"},{"key":"2714_CR3","doi-asserted-by":"crossref","unstructured":"De Duve, C., De Reuck, A. V. & Cameron, M. P. Ciba Foundation Symposium: Lysosomes Vol. 45 (Little, 1963).","DOI":"10.1002\/9780470715314"},{"key":"2714_CR4","doi-asserted-by":"publisher","first-page":"C11","DOI":"10.1083\/jcb.35.2.C11","volume":"35","author":"RL Deter","year":"1967","unstructured":"Deter, R. L., Baudhuin, P. & de Duve, C. Participation of lysosomes in cellular autophagy induced in rat liver by glucagon. J. Cell Biol. 35, C11 (1967).","journal-title":"J. Cell Biol."},{"key":"2714_CR5","doi-asserted-by":"crossref","unstructured":"Blobel, G. Christian de Duve (1917-2013). Nature 498, 300 (2013).","DOI":"10.1038\/498300a"},{"key":"2714_CR6","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/BF02172188","volume":"18","author":"F Ritossa","year":"1962","unstructured":"Ritossa, F. A new puffing pattern induced by temperature shock and DNP in Drosophila. Experientia 18, 571\u2013573 (1962).","journal-title":"Experientia"},{"key":"2714_CR7","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/0022-2836(74)90447-1","volume":"84","author":"A Tissi\u00e9res","year":"1974","unstructured":"Tissi\u00e9res, A., Mitchell, H. K. & Tracy, U. M. Protein synthesis in salivary glands of Drosophila melanogaster: relation to chromosome puffs. J. Mol. Biol. 84, 389\u2013398 (1974).","journal-title":"J. Mol. Biol."},{"key":"2714_CR8","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/0092-8674(78)90346-X","volume":"14","author":"P Schedl","year":"1978","unstructured":"Schedl, P. et al. Two hybrid plasmids with D. melanogaster DNA sequences complementary to mRNA coding for the major heat shock protein. Cell 14, 921\u2013929 (1978).","journal-title":"Cell"},{"key":"2714_CR9","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1080\/17460441.2017.1268596","volume":"12","author":"R Arkwright","year":"2017","unstructured":"Arkwright, R., Pham, T. M., Zonder, J. A. & Dou, Q. P. The preclinical discovery and development of bortezomib for the treatment of mantle cell lymphoma. Expert Opin. Drug Discov. 12, 225\u2013235 (2017).","journal-title":"Expert Opin. Drug Discov."},{"key":"2714_CR10","first-page":"2579","volume":"148","author":"J Neefjes","year":"2004","unstructured":"Neefjes, J., Groothuis, T. A. M. & Dantuma, N. P. The 2004 Nobel Prize in Chemistry for the discovery of ubiquitin-mediated protein degradation. Ned. Tijdschr. Geneeskd 148, 2579\u20132582 (2004).","journal-title":"Ned. Tijdschr. Geneeskd"},{"key":"2714_CR11","doi-asserted-by":"publisher","first-page":"442","DOI":"10.7164\/antibiotics.23.442","volume":"23","author":"C DeBoer","year":"1970","unstructured":"DeBoer, C., Meulman, P., Wnuk, R. & Peterson, D. Geldanamycin, a new antibiotic. J. Antibiot. 23, 442\u2013447 (1970).","journal-title":"J. Antibiot."},{"key":"2714_CR12","doi-asserted-by":"publisher","first-page":"8324","DOI":"10.1073\/pnas.91.18.8324","volume":"91","author":"L Whitesell","year":"1994","unstructured":"Whitesell, L. et al. Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation. Proc. Natl. Acad. Sci. USA 91, 8324\u20138328 (1994).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2714_CR13","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/332462a0","volume":"332","author":"Y Kozutsumi","year":"1988","unstructured":"Kozutsumi, Y. et al. The presence of malfolded proteins in the endoplasmic reticulum signals the induction of glucose-regulated proteins. Nature 332, 462\u2013464 (1988).","journal-title":"Nature"},{"key":"2714_CR14","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1083\/jcb.119.2.301","volume":"119","author":"K Takeshige","year":"1992","unstructured":"Takeshige, K. et al. Autophagy in yeast demonstrated with proteinase-deficient mutants and conditions for its induction. J. Cell Biol. 119, 301\u2013311 (1992).","journal-title":"J. Cell Biol."},{"key":"2714_CR15","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/0014-5793(93)80398-E","volume":"333","author":"M Tsukada","year":"1993","unstructured":"Tsukada, M. & Ohsumi, Y. Isolation and characterization of autophagy-defective mutants of Saccharomyces cerevisiae. FEBS Lett. 333, 169\u2013174 (1993).","journal-title":"FEBS Lett."},{"key":"2714_CR16","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1083\/jcb.12.1.198","volume":"12","author":"TP Ashford","year":"1962","unstructured":"Ashford, T. P. & Porter, K. R. Cytoplasmic components in hepatic cell lysosomes. J. Cell Biol. 12, 198 (1962).","journal-title":"J. Cell Biol."},{"key":"2714_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1089\/rej.2005.8.3","volume":"8","author":"JJ Lemasters","year":"2005","unstructured":"Lemasters, J. J. Selective mitochondrial autophagy, or mitophagy, as a targeted defense against oxidative stress, mitochondrial dysfunction, and aging. Rejuvenation Res. 8, 3\u20135 (2005).","journal-title":"Rejuvenation Res."},{"key":"2714_CR18","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1161\/01.RES.83.2.117","volume":"83","author":"IJ Benjamin","year":"1998","unstructured":"Benjamin, I. J. & McMillan, D. R. Stress (heat shock) proteins: molecular chaperones in cardiovascular biology and disease. Circ. Res. 83, 117\u2013132 (1998).","journal-title":"Circ. Res."},{"key":"2714_CR19","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/0891-5849(93)90046-W","volume":"15","author":"MM Mocanu","year":"1993","unstructured":"Mocanu, M. M. et al. Heat stress attenuates free radical release in the isolated perfused rat heart. Free Radic. Biol. Med. 15, 459\u2013463 (1993).","journal-title":"Free Radic. Biol. Med."},{"key":"2714_CR20","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1161\/01.RES.71.2.288","volume":"71","author":"F Bennardini","year":"1992","unstructured":"Bennardini, F., Wrzosek, A. & Chiesi, M. Alpha B-crystallin in cardiac tissue. Association with actin and desmin filaments. Circ. Res. 71, 288\u2013294 (1992).","journal-title":"Circ. Res."},{"key":"2714_CR21","doi-asserted-by":"publisher","first-page":"10132","DOI":"10.1073\/pnas.0401900101","volume":"101","author":"A Sanbe","year":"2004","unstructured":"Sanbe, A. et al. Desmin-related cardiomyopathy in transgenic mice: a cardiac amyloidosis. Proc. Natl. Acad. Sci. USA 101, 10132\u201310136 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2714_CR22","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.116.003626","volume":"10","author":"C Franssen","year":"2017","unstructured":"Franssen, C. et al. \u03b1-B crystallin reverses high diastolic stiffness of failing human cardiomyocytes. Circ. Heart Fail. 10, e003626 (2017).","journal-title":"Circ. Heart Fail."},{"key":"2714_CR23","doi-asserted-by":"publisher","first-page":"600","DOI":"10.4161\/auto.6.5.11947","volume":"6","author":"M Taneike","year":"2010","unstructured":"Taneike, M. et al. Inhibition of autophagy in the heart induces age-related cardiomyopathy. Autophagy 6, 600\u2013606 (2010).","journal-title":"Autophagy"},{"key":"2714_CR24","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1128\/MCB.01005-15","volume":"36","author":"T Kaizuka","year":"2016","unstructured":"Kaizuka, T. & Mizushima, N. Atg13 is essential for autophagy and cardiac development in mice. Mol. Cell. Biol. 36, 585\u2013595 (2016).","journal-title":"Mol. Cell. Biol."},{"key":"2714_CR25","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1172\/JCI27523","volume":"117","author":"H Zhu","year":"2007","unstructured":"Zhu, H. et al. Cardiac autophagy is a maladaptive response to hemodynamic stress. J. Clin. Invest. 117, 1782\u20131793 (2007).","journal-title":"J. Clin. Invest."},{"key":"2714_CR26","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/nm1574","volume":"13","author":"A Nakai","year":"2007","unstructured":"Nakai, A. et al. The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat. Med. 13, 619\u2013624 (2007).","journal-title":"Nat. Med."},{"key":"2714_CR27","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1083\/jcb.200907015","volume":"188","author":"S Pankiv","year":"2010","unstructured":"Pankiv, S. et al. FYCO1 is a Rab7 effector that binds to LC3 and PI3P to mediate microtubule plus end\u2013directed vesicle transport. J. Cell Biol. 188, 253\u2013269 (2010).","journal-title":"J. Cell Biol."},{"key":"2714_CR28","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.jacbts.2021.01.001","volume":"6","author":"C Kuhn","year":"2021","unstructured":"Kuhn, C. et al. FYCO1 regulates cardiomyocyte autophagy and prevents heart failure due to pressure overload in vivo. JACC Basic Transl. Sci. 6, 365\u2013380 (2021).","journal-title":"JACC Basic Transl. Sci."},{"key":"2714_CR29","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.1073\/pnas.1015081108","volume":"108","author":"DJ Cao","year":"2011","unstructured":"Cao, D. J. et al. Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy. Proc. Natl. Acad. Sci. USA 108, 4123\u20134128 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2714_CR30","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/rai2.12119","volume":"4","author":"H Li","year":"2024","unstructured":"Li, H. et al. Mitochondrial aberrations in systemic lupus erythematosus pathogenesis: insights and therapeutic implications. Rheumatol. Autoimmun. 4, 69\u201380 (2024).","journal-title":"Rheumatol. Autoimmun."},{"key":"2714_CR31","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1161\/CIRCRESAHA.124.323890","volume":"134","author":"JA Hudson","year":"2024","unstructured":"Hudson, J. A. et al. HIV-associated cardiovascular disease pathogenesis: an emerging understanding through imaging and immunology. Circ. Res. 134, 1546\u20131565 (2024).","journal-title":"Circ. Res."},{"key":"2714_CR32","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1152\/physrev.00030.2020","volume":"101","author":"J Ren","year":"2021","unstructured":"Ren, J. et al. Obesity cardiomyopathy: evidence, mechanisms, and therapeutic implications. Physiol. Rev. 101, 1745\u20131807 (2021).","journal-title":"Physiol. Rev."},{"key":"2714_CR33","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1242\/jcs.093849","volume":"125","author":"SM Jin","year":"2012","unstructured":"Jin, S. M. & Youle, R. J. PINK1- and Parkin-mediated mitophagy at a glance. J. Cell Sci. 125, 795\u2013799 (2012).","journal-title":"J. Cell Sci."},{"key":"2714_CR34","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1080\/15384101.2023.2167949","volume":"22","author":"Y Liu","year":"2023","unstructured":"Liu, Y. et al. Emerging role of mitophagy in heart failure: from molecular mechanism to targeted therapy. Cell Cycle 22, 906\u2013918 (2023).","journal-title":"Cell Cycle"},{"key":"2714_CR35","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.freeradbiomed.2018.01.012","volume":"117","author":"RF Ribeiro Junior","year":"2018","unstructured":"Ribeiro Junior, R. F. et al. MitoQ improves mitochondrial dysfunction in heart failure induced by pressure overload. Free Radic. Biol. Med. 117, 18\u201329 (2018).","journal-title":"Free Radic. Biol. Med."},{"key":"2714_CR36","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ijcard.2022.05.025","volume":"361","author":"Y Wu","year":"2022","unstructured":"Wu, Y. et al. PINK1\/Parkin-mediated mitophagy in cardiovascular disease: from pathogenesis to novel therapy. Int. J. Cardiol. 361, 61\u201369 (2022).","journal-title":"Int. J. Cardiol."},{"key":"2714_CR37","doi-asserted-by":"publisher","first-page":"3791","DOI":"10.1111\/bph.14781","volume":"176","author":"CC Hsieh","year":"2019","unstructured":"Hsieh, C. C. et al. Mitochondrial protection by simvastatin against angiotensin II-mediated heart failure. Br. J. Pharmacol. 176, 3791\u20133804 (2019).","journal-title":"Br. J. Pharmacol."},{"key":"2714_CR38","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3389\/fphys.2016.00104","volume":"7","author":"J Gu","year":"2016","unstructured":"Gu, J. et al. Rapamycin inhibits cardiac hypertrophy by promoting autophagy via the MEK\/ERK\/Beclin-1 pathway. Front. Physiol. 7, 104 (2016).","journal-title":"Front. Physiol."},{"key":"2714_CR39","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1080\/15548627.2017.1300224","volume":"13","author":"W Zhang","year":"2017","unstructured":"Zhang, W., Siraj, S., Zhang, R. & Chen, Q. Mitophagy receptor FUNDC1 regulates mitochondrial homeostasis and protects the heart from I\/R injury. Autophagy 13, 1080\u20131081 (2017).","journal-title":"Autophagy"},{"key":"2714_CR40","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/s41418-018-0086-7","volume":"25","author":"H Zhou","year":"2018","unstructured":"Zhou, H. et al. Pathogenesis of cardiac ischemia reperfusion injury is associated with CK2alpha-disturbed mitochondrial homeostasis via suppression of FUNDC1-related mitophagy. Cell Death Differ. 25, 1080\u20131093 (2018).","journal-title":"Cell Death Differ."},{"key":"2714_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04469-y","volume":"13","author":"Y Li","year":"2021","unstructured":"Li, Y. et al. BNIP3L\/NIX-mediated mitophagy: molecular mechanisms and implications for human disease. Cell Death Dis. 13, 14 (2021).","journal-title":"Cell Death Dis."},{"key":"2714_CR42","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1007\/s00018-008-8030-5","volume":"65","author":"RH Houtkooper","year":"2008","unstructured":"Houtkooper, R. H. & Vaz, F. M. Cardiolipin, the heart of mitochondrial metabolism. Cell. Mol. Life Sci. 65, 2493\u20132506 (2008).","journal-title":"Cell. Mol. Life Sci."},{"key":"2714_CR43","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1093\/cvr\/cvs118","volume":"94","author":"CM Mulligan","year":"2012","unstructured":"Mulligan, C. M. et al. Dietary linoleate preserves cardiolipin and attenuates mitochondrial dysfunction in the failing rat heart. Cardiovasc. Res. 94, 460\u2013468 (2012).","journal-title":"Cardiovasc. Res."},{"key":"2714_CR44","doi-asserted-by":"publisher","first-page":"13560","DOI":"10.3390\/ijms252413560","volume":"25","author":"R Raghav","year":"2024","unstructured":"Raghav, R. et al. Cell-penetrating peptide enhances tafazzin gene therapy in mouse model of barth syndrome. Int. J. Mol. Sci. 25, 13560 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"2714_CR45","doi-asserted-by":"publisher","first-page":"24315","DOI":"10.1016\/S0021-9258(18)35767-3","volume":"267","author":"JC Cook","year":"1992","unstructured":"Cook, J. C. & Chock, P. B. Isoforms of mammalian ubiquitin-activating enzyme. J. Biol. Chem. 267, 24315\u201324321 (1992).","journal-title":"J. Biol. Chem."},{"key":"2714_CR46","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/emm.2003.45","volume":"35","author":"YH Kim","year":"2003","unstructured":"Kim, Y. H. et al. Gene expression profiling of oxidative stress on atrial fibrillation in humans. Exp. Mol. Med. 35, 336\u2013349 (2003).","journal-title":"Exp. Mol. Med."},{"key":"2714_CR47","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1161\/01.RES.0000067471.95890.5C","volume":"92","author":"S Kostin","year":"2003","unstructured":"Kostin, S. et al. Myocytes die by multiple mechanisms in failing human hearts. Circ. Res. 92, 715\u2013724 (2003).","journal-title":"Circ. Res."},{"key":"2714_CR48","doi-asserted-by":"publisher","first-page":"R84","DOI":"10.1016\/S0960-9822(00)00287-6","volume":"10","author":"PS Freemont","year":"2000","unstructured":"Freemont, P. S. RING for destruction? Curr. Biol. 10, R84\u2013R87 (2000).","journal-title":"Curr. Biol."},{"key":"2714_CR49","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s42003-020-01289-2","volume":"3","author":"AY Rangrez","year":"2020","unstructured":"Rangrez, A. Y. et al. The E3 ubiquitin ligase HectD3 attenuates cardiac hypertrophy and inflammation in mice. Commun. Biol. 3, 562 (2020).","journal-title":"Commun. Biol."},{"key":"2714_CR50","doi-asserted-by":"publisher","first-page":"10180","DOI":"10.1074\/jbc.M116.752543","volume":"292","author":"A Borlepawar","year":"2017","unstructured":"Borlepawar, A. et al. TRIM24 protein promotes and TRIM32 protein inhibits cardiomyocyte hypertrophy via regulation of dysbindin protein levels. J. Biol. Chem. 292, 10180\u201310196 (2017).","journal-title":"J. Biol. Chem."},{"key":"2714_CR51","doi-asserted-by":"crossref","unstructured":"Krshnan, L., van de Weijer, M. L. & Carvalho, P. Endoplasmic reticulum-associated protein degradation. Cold Spring Harb. Perspect. Biol. 14, a041247 (2022).","DOI":"10.1101\/cshperspect.a041247"},{"key":"2714_CR52","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1161\/CIRCULATIONAHA.122.061557","volume":"147","author":"EA Blackwood","year":"2023","unstructured":"Blackwood, E. A. et al. Noncanonical form of ERAD regulates cardiac hypertrophy. Circulation 147, 66\u201382 (2023).","journal-title":"Circulation"},{"key":"2714_CR53","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2318822121","volume":"121","author":"RA Faulkner","year":"2024","unstructured":"Faulkner, R. A. et al. Direct binding to sterols accelerates endoplasmic reticulum-associated degradation of HMG CoA reductase. Proc. Natl. Acad. Sci. USA 121, e2318822121 (2024).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2714_CR54","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1158\/1078-0432.CCR-08-0132","volume":"15","author":"U Banerji","year":"2009","unstructured":"Banerji, U. Heat shock protein 90 as a drug target: some like it hot. Clin. Cancer Res. 15, 9\u201314 (2009).","journal-title":"Clin. Cancer Res."},{"key":"2714_CR55","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1158\/0008-5472.CAN-13-3263","volume":"74","author":"DA Proia","year":"2014","unstructured":"Proia, D. A. & Bates, R. C. Ganetespib and HSP90: translating preclinical hypotheses into clinical promise. Cancer Res. 74, 1294\u20131300 (2014).","journal-title":"Cancer Res."},{"key":"2714_CR56","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1172\/JCI117030","volume":"93","author":"R Mestril","year":"1994","unstructured":"Mestril, R. et al. Expression of inducible stress protein 70 in rat heart myogenic cells confers protection against simulated ischemia-induced injury. J. Clin. Invest. 93, 759\u2013767 (1994).","journal-title":"J. Clin. Invest."},{"key":"2714_CR57","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1161\/01.CIR.89.1.355","volume":"89","author":"MM Hutter","year":"1994","unstructured":"Hutter, M. M., Sievers, R. E., Barbosa, V. & Wolfe, C. L. Heat-shock protein induction in rat hearts. A direct correlation between the amount of heat-shock protein induced and the degree of myocardial protection. Circulation 89, 355\u2013360 (1994).","journal-title":"Circulation"},{"key":"2714_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1195464","volume":"10","author":"Y Zou","year":"2023","unstructured":"Zou, Y. et al. Mechanistic insights into heat shock protein 27, a potential therapeutic target for cardiovascular diseases. Front. Cardiovasc. Med. 10, 1195464 (2023).","journal-title":"Front. Cardiovasc. Med."},{"key":"2714_CR59","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.3390\/ijms18061279","volume":"18","author":"CI Chude","year":"2017","unstructured":"Chude, C. I. & Amaravadi, R. K. Targeting autophagy in cancer: update on clinical trials and novel inhibitors. Int. J. Mol. Sci. 18, 1279 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"2714_CR60","first-page":"352","volume":"10","author":"M Bielawska","year":"2023","unstructured":"Bielawska, M., Warszy\u0144ska, M., Stefa\u0144ska, M. & B\u0142yszczuk, P. Autophagy in heart failure: insights into mechanisms and therapeutic implications. J. Cardiovasc. Dev. Dis. 10, 352 (2023).","journal-title":"J. Cardiovasc. Dev. Dis."},{"key":"2714_CR61","doi-asserted-by":"publisher","first-page":"369","DOI":"10.21873\/cgp.20196","volume":"17","author":"M Ondrej","year":"2020","unstructured":"Ondrej, M. et al. Lys05\u2014a promising autophagy inhibitor in the radiosensitization battle: phosphoproteomic perspective. Cancer Genomics Proteom. 17, 369\u2013382 (2020).","journal-title":"Cancer Genomics Proteom."},{"key":"2714_CR62","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1002\/ejhf.2922","volume":"25","author":"M Bohm","year":"2023","unstructured":"Bohm, M. et al. Liver tests, cardiovascular outcomes and effects of empagliflozin in patients with heart failure and preserved ejection fraction: the EMPEROR-Preserved trial. Eur. J. Heart Fail. 25, 1375\u20131383 (2023).","journal-title":"Eur. J. Heart Fail."},{"key":"2714_CR63","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/j.cell.2018.04.028","volume":"173","author":"I Koren","year":"2018","unstructured":"Koren, I. et al. The eukaryotic proteome is shaped by E3 ubiquitin ligases targeting C-terminal degrons. Cell 173, 1622\u20131635.e1614 (2018).","journal-title":"Cell"},{"key":"2714_CR64","doi-asserted-by":"publisher","first-page":"e175265","DOI":"10.1172\/JCI175265","volume":"134","author":"H Yoon","year":"2024","unstructured":"Yoon, H., Rutter, J. C., Li, Y.-D. & Ebert, B. L. Induced protein degradation for therapeutics: past and future. J. Clin. Invest 134, e175265 (2024).","journal-title":"J. Clin. Invest"},{"key":"2714_CR65","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1158\/1535-7163.MCT-23-0747","volume":"23","author":"KA Rutherford","year":"2024","unstructured":"Rutherford, K. A. & McManus, K. J. PROTACs: current and future potential as a precision medicine strategy to combat cancer. Mol. Cancer Ther. 23, 454\u2013463 (2024).","journal-title":"Mol. Cancer Ther."},{"key":"2714_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02024-9","volume":"23","author":"C Wang","year":"2024","unstructured":"Wang, C. et al. New-generation advanced PROTACs as potential therapeutic agents in cancer therapy. Mol. Cancer 23, 110 (2024).","journal-title":"Mol. Cancer"},{"key":"2714_CR67","doi-asserted-by":"publisher","first-page":"3302","DOI":"10.1038\/s41401-025-01616-5","volume":"46","author":"B Lu","year":"2025","unstructured":"Lu, B. et al. Identification of AKOS, a Chikungunya virus inhibitor, as a USP14 inhibitor for colorectal cancer treatment. Acta Pharmacol. Sin. 46, 3302\u20133313 (2025).","journal-title":"Acta Pharmacol. Sin."},{"key":"2714_CR68","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1161\/CIRCRESAHA.116.310266","volume":"120","author":"JK Jin","year":"2017","unstructured":"Jin, J. K. et al. ATF6 decreases myocardial ischemia\/reperfusion damage and links er stress and oxidative stress signaling pathways in the heart. Circ. Res. 120, 862\u2013875 (2017).","journal-title":"Circ. Res."},{"key":"2714_CR69","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1161\/CIRCRESAHA.115.306993","volume":"117","author":"S Doroudgar","year":"2015","unstructured":"Doroudgar, S. et al. Hrd1 and ER-associated protein degradation, ERAD, are critical elements of the adaptive ER stress response in cardiac myocytes. Circ. Res. 117, 536\u2013546 (2015).","journal-title":"Circ. Res."},{"key":"2714_CR70","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.cell.2010.02.034","volume":"140","author":"GS Hotamisligil","year":"2010","unstructured":"Hotamisligil, G. S. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 140, 900\u2013917 (2010).","journal-title":"Cell"},{"key":"2714_CR71","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.molmet.2014.08.003","volume":"3","author":"DC Henstridge","year":"2014","unstructured":"Henstridge, D. C., Whitham, M. & Febbraio, M. A. Chaperoning to the metabolic party: the emerging therapeutic role of heat-shock proteins in obesity and type 2 diabetes. Mol. Metab. 3, 781\u2013793 (2014).","journal-title":"Mol. Metab."},{"key":"2714_CR72","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.jhep.2018.01.003","volume":"68","author":"K Levada","year":"2018","unstructured":"Levada, K. et al. Hsp72 protects against liver injury via attenuation of hepatocellular death, oxidative stress, and JNK signaling. J. Hepatol. 68, 996\u20131005 (2018).","journal-title":"J. Hepatol."},{"key":"2714_CR73","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1042\/CS20130678","volume":"126","author":"M Krause","year":"2014","unstructured":"Krause, M. et al. Elevated levels of extracellular heat-shock protein 72 (eHSP72) are positively correlated with insulin resistance in vivo and cause pancreatic \u03b2-cell dysfunction and death in vitro. Clin. Sci. 126, 739\u2013752 (2014).","journal-title":"Clin. Sci."},{"key":"2714_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-024-00664-z","volume":"12","author":"Z Nie","year":"2024","unstructured":"Nie, Z. et al. Heat shock proteins (HSPs) in non-alcoholic fatty liver disease (NAFLD): from molecular mechanisms to therapeutic avenues. Biomark. Res 12, 120 (2024).","journal-title":"Biomark. Res"},{"key":"2714_CR75","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jdiacomp.2017.10.004","volume":"32","author":"S Jakhotia","year":"2018","unstructured":"Jakhotia, S. et al. Circulating levels of Hsp27 in microvascular complications of diabetes: prospects as a biomarker of diabetic nephropathy. J. Diab. Complicat. 32, 221\u2013225 (2018).","journal-title":"J. Diab. Complicat."},{"key":"2714_CR76","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1093\/eurheartj\/ehl081","volume":"27","author":"A Shamaei-Tousi","year":"2006","unstructured":"Shamaei-Tousi, A. et al. Association between plasma levels of heat shock protein 60 and cardiovascular disease in patients with diabetes mellitus. Eur. Heart J. 27, 1565\u20131570 (2006).","journal-title":"Eur. Heart J."},{"key":"2714_CR77","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s00125-023-05869-9","volume":"66","author":"S-W Weng","year":"2023","unstructured":"Weng, S.-W. et al. Chaperonin counteracts diet-induced non-alcoholic fatty liver disease by aiding sirtuin 3 in the control of fatty acid oxidation. Diabetologia 66, 913\u2013930 (2023).","journal-title":"Diabetologia"},{"key":"2714_CR78","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.1007\/s12033-024-01251-1","volume":"67","author":"V Nithyasree","year":"2025","unstructured":"Nithyasree, V. et al. Role of HSP90 in type 2 diabetes mellitus and its association with liver diseases. Mol. Biotechnol. 67, 2997\u20133009 (2025).","journal-title":"Mol. Biotechnol."},{"key":"2714_CR79","doi-asserted-by":"publisher","first-page":"E268","DOI":"10.1210\/jc.2010-1681","volume":"96","author":"J Kovsan","year":"2011","unstructured":"Kovsan, J. et al. Altered autophagy in human adipose tissues in obesity. J. Clin. Endocrinol. Metab. 96, E268\u2013E277 (2011).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2714_CR80","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1080\/21623945.2017.1394537","volume":"7","author":"Q Xu","year":"2018","unstructured":"Xu, Q. et al. Adipose tissue autophagy related gene expression is associated with glucometabolic status in human obesity. Adipocyte 7, 12\u201319 (2018).","journal-title":"Adipocyte"},{"key":"2714_CR81","doi-asserted-by":"publisher","first-page":"5866","DOI":"10.1210\/en.2012-1625","volume":"153","author":"HJ Jansen","year":"2012","unstructured":"Jansen, H. J. et al. Autophagy activity is up-regulated in adipose tissue of obese individuals and modulates proinflammatory cytokine expression. Endocrinology 153, 5866\u20135874 (2012).","journal-title":"Endocrinology"},{"key":"2714_CR82","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13567","volume":"24","author":"L Wang","year":"2023","unstructured":"Wang, L., O\u2019Kane, A. M., Zhang, Y. & Ren, J. Maternal obesity and offspring health: adapting metabolic changes through autophagy and mitophagy. Obes. Rev. 24, e13567 (2023).","journal-title":"Obes. Rev."},{"key":"2714_CR83","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.cell.2013.07.035","volume":"154","author":"C He","year":"2013","unstructured":"He, C. et al. Beclin 2 functions in autophagy, degradation of G protein-coupled receptors, and metabolism. Cell 154, 1085\u20131099 (2013).","journal-title":"Cell"},{"key":"2714_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5934","volume":"5","author":"YM Lim","year":"2014","unstructured":"Lim, Y. M. et al. Systemic autophagy insufficiency compromises adaptation to metabolic stress and facilitates progression from obesity to diabetes. Nat. Commun. 5, 4934 (2014).","journal-title":"Nat. Commun."},{"key":"2714_CR85","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/ncb2718","volume":"15","author":"C Settembre","year":"2013","unstructured":"Settembre, C. et al. TFEB controls cellular lipid metabolism through a starvation-induced autoregulatory loop. Nat. Cell Biol. 15, 647\u2013658 (2013).","journal-title":"Nat. Cell Biol."},{"key":"2714_CR86","doi-asserted-by":"publisher","first-page":"E530","DOI":"10.1152\/ajpendo.00640.2012","volume":"305","author":"C Zhang","year":"2013","unstructured":"Zhang, C. et al. Autophagy is involved in adipogenic differentiation by repressesing proteasome-dependent PPAR\u03b32 degradation. Am. J. Physiol. Endocrinol. Metab. 305, E530\u2013E539 (2013).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"2714_CR87","doi-asserted-by":"publisher","first-page":"19860","DOI":"10.1073\/pnas.0906048106","volume":"106","author":"Y Zhang","year":"2009","unstructured":"Zhang, Y. et al. Adipose-specific deletion of autophagy-related gene 7 (atg7) in mice reveals a role in adipogenesis. Proc. Natl. Acad. Sci. USA 106, 19860\u201319865 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2714_CR88","doi-asserted-by":"publisher","first-page":"32324","DOI":"10.1074\/jbc.M111.254417","volume":"286","author":"Q Meng","year":"2011","unstructured":"Meng, Q. & Cai, D. Defective hypothalamic autophagy directs the central pathogenesis of obesity via the IkappaB kinase beta (IKKbeta)\/NF-kappaB pathway. J. Biol. Chem. 286, 32324\u201332332 (2011).","journal-title":"J. Biol. Chem."},{"key":"2714_CR89","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1210\/en.2011-1882","volume":"153","author":"W Quan","year":"2012","unstructured":"Quan, W. et al. Role of hypothalamic proopiomelanocortin neuron autophagy in the control of appetite and leptin response. Endocrinology 153, 1817\u20131826 (2012).","journal-title":"Endocrinology"},{"key":"2714_CR90","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1002\/jsfa.12429","volume":"103","author":"X Wang","year":"2023","unstructured":"Wang, X. et al. Docosahexaenoic acid-acylated astaxanthin monoester ameliorates chronic high-fat diet-induced autophagy dysfunction via ULK1 pathway in the hypothalamus of mice. J. Sci. Food Agric. 103, 2378\u20132388 (2023).","journal-title":"J. Sci. Food Agric."},{"key":"2714_CR91","doi-asserted-by":"crossref","unstructured":"Jin, S. et al. Mechanisms and therapeutic implications of selective autophagy in nonalcoholic fatty liver disease. J. Adv. Res., 67, 317\u2013329 (2025).","DOI":"10.1016\/j.jare.2024.01.027"},{"key":"2714_CR92","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1111\/hepr.13071","volume":"48","author":"H Fukushima","year":"2018","unstructured":"Fukushima, H. et al. Formation of p62-positive inclusion body is associated with macrophage polarization in non-alcoholic fatty liver disease. Hepatol. Res. 48, 757\u2013767 (2018).","journal-title":"Hepatol. Res."},{"key":"2714_CR93","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.601627","volume":"11","author":"A Grefhorst","year":"2020","unstructured":"Grefhorst, A. et al. The Role of Lipophagy in the Development and Treatment of Non-Alcoholic Fatty Liver Disease. Front. Endocrinol. 11, 601627 (2020).","journal-title":"Front. Endocrinol."},{"key":"2714_CR94","doi-asserted-by":"publisher","first-page":"850","DOI":"10.3389\/fphys.2020.00850","volume":"11","author":"S Carotti","year":"2020","unstructured":"Carotti, S. et al. Lipophagy impairment is associated with disease progression in NAFLD. Front. Physiol. 11, 850 (2020).","journal-title":"Front. Physiol."},{"key":"2714_CR95","doi-asserted-by":"crossref","unstructured":"Mastoridou, E. M., Goussia, A. C., Kanavaros, P. & Charchanti, A. V. Involvement of lipophagy and chaperone-mediated autophagy in the pathogenesis of non-alcoholic fatty liver disease by regulation of lipid droplets. Int. J. Mol. Sci. 24, 15891 (2023).","DOI":"10.3390\/ijms242115891"},{"key":"2714_CR96","doi-asserted-by":"crossref","unstructured":"Jonas, W. et al. Alterations of lipid profile in livers with impaired lipophagy. Int. J. Mol. Sci. 23, 11863 (2022).","DOI":"10.3390\/ijms231911863"},{"key":"2714_CR97","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.jhep.2016.06.029","volume":"65","author":"YC Lin","year":"2016","unstructured":"Lin, Y. C. et al. Variants in the autophagy-related gene IRGM confer susceptibility to non-alcoholic fatty liver disease by modulating lipophagy. J. Hepatol. 65, 1209\u20131216 (2016).","journal-title":"J. Hepatol."},{"key":"2714_CR98","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1124003","volume":"14","author":"X Tan","year":"2023","unstructured":"Tan, X. et al. The essential effect of mTORC1-dependent lipophagy in non-alcoholic fatty liver disease. Front. Pharmacol. 14, 1124003 (2023).","journal-title":"Front. Pharmacol."},{"key":"2714_CR99","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.202200812","volume":"68","author":"L Guan","year":"2024","unstructured":"Guan, L. et al. Naringin protects against non-alcoholic fatty liver disease by promoting autophagic flux and lipophagy. Mol. Nutr. Food Res. 68, e2200812 (2024).","journal-title":"Mol. Nutr. Food Res."},{"key":"2714_CR100","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.bbrc.2018.02.199","volume":"498","author":"C Cui","year":"2018","unstructured":"Cui, C. et al. PINK1-Parkin alleviates metabolic stress induced by obesity in adipose tissue and in 3T3-L1 preadipocytes. Biochem. Biophys. Res. Commun. 498, 445\u2013452 (2018).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2714_CR101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.metabol.2017.03.010","volume":"72","author":"MY Shiau","year":"2017","unstructured":"Shiau, M. Y. et al. Role of PARL-PINK1-Parkin pathway in adipocyte differentiation. Metabolism 72, 1\u201317 (2017).","journal-title":"Metabolism"},{"key":"2714_CR102","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1080\/15548627.2020.1753002","volume":"17","author":"MS Ko","year":"2021","unstructured":"Ko, M. S. et al. Mitophagy deficiency increases NLRP3 to induce brown fat dysfunction in mice. Autophagy 17, 1205\u20131221 (2021).","journal-title":"Autophagy"},{"key":"2714_CR103","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/s41392-023-01503-7","volume":"8","author":"S Wang","year":"2023","unstructured":"Wang, S. et al. The mitophagy pathway and its implications in human diseases. Signal Transduct. Target Ther. 8, 304 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"2714_CR104","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/s41374-018-0177-6","volume":"99","author":"NP Zhang","year":"2019","unstructured":"Zhang, N. P. et al. Impaired mitophagy triggers NLRP3 inflammasome activation during the progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis. Lab. Invest. 99, 749\u2013763 (2019).","journal-title":"Lab. Invest."},{"key":"2714_CR105","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1111\/bph.15083","volume":"177","author":"X Li","year":"2020","unstructured":"Li, X. et al. Cyanidin-3-O-glucoside improves non-alcoholic fatty liver disease by promoting PINK1-mediated mitophagy in mice. Br. J. Pharmacol. 177, 3591\u20133607 (2020).","journal-title":"Br. J. Pharmacol."},{"key":"2714_CR106","doi-asserted-by":"crossref","unstructured":"Undamatla, R. et al. 371-OR: Reduced hepatic expression of the mitochondrial quality control factor PARKIN hastens the progression of NAFLD in mice and is associated with NASH in patients. Diabetes. 69, 371-OR (2020).","DOI":"10.2337\/db20-371-OR"},{"key":"2714_CR107","doi-asserted-by":"publisher","first-page":"12197","DOI":"10.3390\/ijms232012197","volume":"23","author":"M Qiu","year":"2022","unstructured":"Qiu, M., Chen, J., Li, X. & Zhuang, J. Intersection of the ubiquitin\u2013proteasome system with oxidative stress in cardiovascular disease. Int. J. Mol. Sci. 23, 12197 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"2714_CR108","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1089\/ars.2014.5939","volume":"23","author":"A D\u00edaz-Ruiz","year":"2015","unstructured":"D\u00edaz-Ruiz, A. et al. Proteasome dysfunction associated to oxidative stress and proteotoxicity in adipocytes compromises insulin sensitivity in human obesity. Antioxid. Redox Signal 23, 597\u2013612 (2015).","journal-title":"Antioxid. Redox Signal"},{"key":"2714_CR109","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.metabol.2009.05.020","volume":"58","author":"T-L Chang","year":"2009","unstructured":"Chang, T.-L. et al. The roles of ubiquitin and 26S proteasome in human obesity. Metabolism 58, 1643\u20131648 (2009).","journal-title":"Metabolism"},{"key":"2714_CR110","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1210\/en.2014-1090","volume":"155","author":"LM Ignacio-Souza","year":"2014","unstructured":"Ignacio-Souza, L. M. et al. Defective regulation of the ubiquitin\/proteasome system in the hypothalamus of obese male mice. Endocrinology 155, 2831\u20132844 (2014).","journal-title":"Endocrinology"},{"key":"2714_CR111","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1002\/oby.21081","volume":"23","author":"LM Bollinger","year":"2015","unstructured":"Bollinger, L. M. et al. Skeletal muscle myotubes in severe obesity exhibit altered ubiquitin-proteasome and autophagic\/lysosomal proteolytic flux. Obesity 23, 1185\u20131193 (2015).","journal-title":"Obesity"},{"key":"2714_CR112","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/dom.12677","volume":"18","author":"X-D Yang","year":"2016","unstructured":"Yang, X.-D., Xiang, D.-X. & Yang, Y.-Y. Role of E3 ubiquitin ligases in insulin resistance. Diab. Obes. Metab. 18, 747\u2013754 (2016).","journal-title":"Diab. Obes. Metab."},{"key":"2714_CR113","doi-asserted-by":"publisher","first-page":"42394","DOI":"10.1074\/jbc.C200444200","volume":"277","author":"L Rui","year":"2002","unstructured":"Rui, L. et al. SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J. Biol. Chem. 277, 42394\u201342398 (2002).","journal-title":"J. Biol. Chem."},{"key":"2714_CR114","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nature11834","volume":"494","author":"R Song","year":"2013","unstructured":"Song, R. et al. Central role of E3 ubiquitin ligase MG53 in insulin resistance and metabolic disorders. Nature 494, 375\u2013379 (2013).","journal-title":"Nature"},{"key":"2714_CR115","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28641-w","volume":"13","author":"M Xu","year":"2022","unstructured":"Xu, M. et al. The E3 ubiquitin-protein ligase Trim31 alleviates non-alcoholic fatty liver disease by targeting Rhbdf2 in mouse hepatocytes. Nat. Commun. 13, 1052 (2022).","journal-title":"Nat. Commun."},{"key":"2714_CR116","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1002\/hep.28971","volume":"65","author":"FJ Yan","year":"2017","unstructured":"Yan, F. J. et al. The E3 ligase tripartite motif 8 targets TAK1 to promote insulin resistance and steatohepatitis. Hepatology 65, 1492\u20131511 (2017).","journal-title":"Hepatology"},{"key":"2714_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110897","volume":"124","author":"Z Zhu","year":"2023","unstructured":"Zhu, Z. et al. E3 ubiquitin ligase Siah1 aggravates NAFLD through Scp2 ubiquitination. Int. Immunopharmacol. 124, 110897 (2023).","journal-title":"Int. Immunopharmacol."},{"key":"2714_CR118","doi-asserted-by":"crossref","unstructured":"Qi, W. et al. The critical role of BTRC in hepatic steatosis as an ATGL E3 ligase. J. Mol. Cell. Biol. 15, mjad064 (2024).","DOI":"10.1093\/jmcb\/mjad064"},{"key":"2714_CR119","doi-asserted-by":"publisher","first-page":"7631","DOI":"10.1096\/fj.201902952RR","volume":"34","author":"X Zhang","year":"2020","unstructured":"Zhang, X. et al. Smurf1 aggravates non-alcoholic fatty liver disease by stabilizing SREBP-1c in an E3 activity-independent manner. FASEB J. 34, 7631\u20137643 (2020).","journal-title":"FASEB J."},{"key":"2714_CR120","doi-asserted-by":"publisher","first-page":"550","DOI":"10.2337\/db13-0802","volume":"63","author":"A Marino","year":"2014","unstructured":"Marino, A. et al. ITCH deficiency protects from diet-induced obesity. Diabetes 63, 550\u2013561 (2014).","journal-title":"Diabetes"},{"key":"2714_CR121","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.immuni.2014.11.013","volume":"41","author":"S Yang","year":"2014","unstructured":"Yang, S. et al. The E3 ubiquitin ligase Pellino3 protects against obesity-induced inflammation and insulin resistance. Immunity 41, 973\u2013987 (2014).","journal-title":"Immunity"},{"key":"2714_CR122","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202001800","volume":"7","author":"C Wang","year":"2020","unstructured":"Wang, C. et al. E3 ligase FBXW2 is a new therapeutic target in obesity and atherosclerosis. Adv. Sci. 7, 2001800 (2020).","journal-title":"Adv. Sci."},{"key":"2714_CR123","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.yjmcc.2018.11.006","volume":"126","author":"D Chandra","year":"2019","unstructured":"Chandra, D. et al. The SCFFBXO3 ubiquitin E3 ligase regulates inflammation in atherosclerosis. J. Mol. Cell. Cardiol. 126, 50\u201359 (2019).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"2714_CR124","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s42003-025-07839-w","volume":"8","author":"Q Liu","year":"2025","unstructured":"Liu, Q. et al. Peli1, regulated by m(6)A modification, suppresses NLRP3 inflammasome activation in atherosclerosis by inhibiting YB-1. Commun. Biol. 8, 457 (2025).","journal-title":"Commun. Biol."},{"key":"2714_CR125","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s00125-018-4754-4","volume":"62","author":"ES Coyne","year":"2019","unstructured":"Coyne, E. S. et al. The deubiquitinating enzyme USP19 modulates adipogenesis and potentiates high-fat-diet-induced obesity and glucose intolerance in mice. Diabetologia 62, 136\u2013146 (2019).","journal-title":"Diabetologia"},{"key":"2714_CR126","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1002\/jcsm.12777","volume":"12","author":"A Kim","year":"2021","unstructured":"Kim, A. et al. Ablation of USP21 in skeletal muscle promotes oxidative fibre phenotype, inhibiting obesity and type 2 diabetes. J. Cachexia Sarcopenia Muscle 12, 1669\u20131689 (2021).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"2714_CR127","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41586-020-2928-y","volume":"588","author":"X-Y Lu","year":"2020","unstructured":"Lu, X.-Y. et al. Feeding induces cholesterol biosynthesis via the mTORC1\u2013USP20\u2013HMGCR axis. Nature 588, 479\u2013484 (2020).","journal-title":"Nature"},{"key":"2714_CR128","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07185-y","volume":"9","author":"B Liu","year":"2018","unstructured":"Liu, B. et al. Proteome-wide analysis of USP14 substrates revealed its role in hepatosteatosis via stabilization of FASN. Nat. Commun. 9, 4770 (2018).","journal-title":"Nat. Commun."},{"key":"2714_CR129","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.3390\/ijms24043219","volume":"24","author":"H Kitamura","year":"2023","unstructured":"Kitamura, H. Ubiquitin-specific proteases (USPs) and metabolic disorders. Int. J. Mol. Sci. 24, 3219 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"2714_CR130","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1002\/hep.29889","volume":"68","author":"Y Zhao","year":"2018","unstructured":"Zhao, Y. et al. Ubiquitin-specific protease 4 is an endogenous negative regulator of metabolic dysfunctions in nonalcoholic fatty liver disease in mice. Hepatology 68, 897\u2013917 (2018).","journal-title":"Hepatology"},{"key":"2714_CR131","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1002\/hep.30062","volume":"68","author":"P Luo","year":"2018","unstructured":"Luo, P. et al. Ubiquitin-specific peptidase 10 (USP10) inhibits hepatic steatosis, insulin resistance, and inflammation through Sirt6. Hepatology 68, 1786\u20131803 (2018).","journal-title":"Hepatology"},{"key":"2714_CR132","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1002\/hep.29375","volume":"66","author":"S An","year":"2017","unstructured":"An, S. et al. USP18 protects against hepatic steatosis and insulin resistance through its deubiquitinating activity. Hepatology 66, 1866\u20131884 (2017).","journal-title":"Hepatology"},{"key":"2714_CR133","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1210\/me.2013-1420","volume":"28","author":"JA Hall","year":"2014","unstructured":"Hall, J. A., Tabata, M., Rodgers, J. T. & Puigserver, P. USP7 attenuates hepatic gluconeogenesis through modulation of FoxO1 gene promoter occupancy. Mol. Endocrinol. 28, 912\u2013924 (2014).","journal-title":"Mol. Endocrinol."},{"key":"2714_CR134","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45633-0","volume":"15","author":"LL Lin","year":"2024","unstructured":"Lin, L. L. et al. SEL1L-HRD1 interaction is required to form a functional HRD1 ERAD complex. Nat. Commun. 15, 1440 (2024).","journal-title":"Nat. Commun."},{"key":"2714_CR135","doi-asserted-by":"crossref","unstructured":"Mao, H. & Qi, L. 1528-P: hypothalamic SEL1L-HRD1 ER-associated degradation is indispensable for leptin signaling in diet-induced obesity by degrading misfolded leptin receptor. Diabetes. 72, 1528-P (2023).","DOI":"10.2337\/db23-1528-P"},{"key":"2714_CR136","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1172\/JCI96420","volume":"128","author":"GH Kim","year":"2018","unstructured":"Kim, G. H. et al. Hypothalamic ER-associated degradation regulates POMC maturation, feeding, and age-associated obesity. J. Clin. Invest. 128, 1125\u20131140 (2018).","journal-title":"J. Clin. Invest."},{"key":"2714_CR137","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.cmet.2018.02.021","volume":"27","author":"H Luo","year":"2018","unstructured":"Luo, H. et al. AIDA selectively mediates downregulation of fat synthesis enzymes by ERAD to retard intestinal fat absorption and prevent obesity. Cell Metab. 27, 843\u2013853.e846 (2018).","journal-title":"Cell Metab."},{"key":"2714_CR138","doi-asserted-by":"crossref","unstructured":"Chen, X. et al. SEL1L-HRD1 ERAD-autophagy interplay maintains mitochondrial homeostasis in brown adipocytes. Proc. Natl. Acad. Sci. USA 123, e2529914123 (2026)","DOI":"10.1073\/pnas.2529914123"},{"key":"2714_CR139","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1126\/science.aay2494","volume":"368","author":"Z Zhou","year":"2020","unstructured":"Zhou, Z. et al. Endoplasmic reticulum-associated degradation regulates mitochondrial dynamics in brown adipocytes. Science 368, 54\u201360 (2020).","journal-title":"Science"},{"key":"2714_CR140","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101192","volume":"49","author":"H Kim","year":"2021","unstructured":"Kim, H. et al. Regulation of hepatic circadian metabolism by the E3 ubiquitin ligase HRD1-controlled CREBH\/PPAR\u03b1 transcriptional program. Mol. Metab. 49, 101192 (2021).","journal-title":"Mol. Metab."},{"key":"2714_CR141","doi-asserted-by":"crossref","unstructured":"Bhattacharya, A. et al. Hepatic Sel1L-Hrd1 ER-associated degradation (ERAD) manages FGF21 levels and systemic metabolism via CREBH. EMBO J. 37, e99277 (2018).","DOI":"10.15252\/embj.201899277"},{"key":"2714_CR142","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06091-7","volume":"9","author":"J Wei","year":"2018","unstructured":"Wei, J. et al. ER-associated ubiquitin ligase HRD1 programs liver metabolism by targeting multiple metabolic enzymes. Nat. Commun. 9, 3659 (2018).","journal-title":"Nat. Commun."},{"key":"2714_CR143","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2020.154349","volume":"114","author":"K Li","year":"2021","unstructured":"Li, K. et al. Hrd1-mediated ACLY ubiquitination alleviate NAFLD in db\/db mice. Metabolism 114, 154349 (2021).","journal-title":"Metabolism"},{"key":"2714_CR144","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32025-5","volume":"13","author":"H Chen","year":"2022","unstructured":"Chen, H. et al. Regulated degradation of HMG CoA reductase requires conformational changes in sterol-sensing domain. Nat. Commun. 13, 4273 (2022).","journal-title":"Nat. Commun."},{"key":"2714_CR145","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1194\/jlr.M011726","volume":"52","author":"EA Fisher","year":"2011","unstructured":"Fisher, E. A., Khanna, N. A. & McLeod, R. S. Ubiquitination regulates the assembly of VLDL in HepG2 cells and is the committing step of the apoB-100 ERAD pathway. J. Lipid Res. 52, 1170\u20131180 (2011).","journal-title":"J. Lipid Res."},{"key":"2714_CR146","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1172\/JCI134874","volume":"130","author":"N Shrestha","year":"2020","unstructured":"Shrestha, N. et al. Sel1L-Hrd1 ER-associated degradation maintains \u03b2 cell identity via TGF-\u03b2 signaling. J. Clin. Invest. 130, 3499\u20133510 (2020).","journal-title":"J. Clin. Invest."},{"key":"2714_CR147","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1055\/s-0028-1128142","volume":"41","author":"B Liter\u00e1ti-Nagy","year":"2009","unstructured":"Liter\u00e1ti-Nagy, B. et al. Improvement of insulin sensitivity by a novel drug, BGP-15, in insulin-resistant patients: a proof of concept randomized double-blind clinical trial. Horm. Metab. Res. 41, 374\u2013380 (2009).","journal-title":"Horm. Metab. Res."},{"key":"2714_CR148","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-04880-x","volume":"22","author":"L Longhitano","year":"2024","unstructured":"Longhitano, L. et al. +)-Lipoic acid reduces mitochondrial unfolded protein response and attenuates oxidative stress and aging in an in vitro model of non-alcoholic fatty liver disease. J. Transl. Med. 22, 82 (2024).","journal-title":"J. Transl. Med."},{"key":"2714_CR149","doi-asserted-by":"publisher","first-page":"8795","DOI":"10.3390\/ijms24108795","volume":"24","author":"J Ma","year":"2023","unstructured":"Ma, J. et al. Isoquercitrin Attenuates Steatohepatitis by Inhibition of the Activated NLRP3 Inflammasome through HSP90. Int. J. Mol. Sci. 24, 8795 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"2714_CR150","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1152\/japplphysiol.00811.2015","volume":"120","author":"DC Henstridge","year":"2016","unstructured":"Henstridge, D. C., Febbraio, M. A. & Hargreaves, M. Heat shock proteins and exercise adaptations. Our knowledge thus far and the road still ahead. J. Appl Physiol. 120, 683\u2013691 (2016).","journal-title":"J. Appl Physiol."},{"key":"2714_CR151","first-page":"374","volume":"18","author":"M Krause","year":"2015","unstructured":"Krause, M., Ludwig, M. S., Heck, T. G. & Takahashi, H. K. Heat shock proteins and heat therapy for type 2 diabetes: pros and cons. Curr. Opin. Clin. Nutr. Metab. Care. 18, 374\u2013380 (2015).","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care."},{"key":"2714_CR152","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1073\/pnas.0705799105","volume":"105","author":"J Chung","year":"2008","unstructured":"Chung, J. et al. HSP72 protects against obesity-induced insulin resistance. Proc. Natl. Acad. Sci. USA 105, 1739\u20131744 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2714_CR153","doi-asserted-by":"publisher","first-page":"H3052","DOI":"10.1152\/ajpheart.01355.2006","volume":"292","author":"S Gupta","year":"2007","unstructured":"Gupta, S. & Knowlton, A. A. HSP60 trafficking in adult cardiac myocytes: role of the exosomal pathway. Am. J. Physiol. Heart Circ. Physiol. 292, H3052\u2013H3056 (2007).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"2714_CR154","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.622153","volume":"11","author":"T Li","year":"2020","unstructured":"Li, T. et al. Empagliflozin Alleviates Hepatic Steatosis by Activating the AMPK-TET2-Autophagy Pathway in vivo and in vitro. Front. Pharmacol. 11, 622153 (2020).","journal-title":"Front. Pharmacol."},{"key":"2714_CR155","doi-asserted-by":"publisher","DOI":"10.2174\/0115733998276570231222105959","volume":"20","author":"H Yaribeygi","year":"2024","unstructured":"Yaribeygi, H. et al. Glp-1 mimetics and autophagy in diabetic milieu: state-of-the-art. Curr. Diab. Rev. 20, e250124226181 (2024).","journal-title":"Curr. Diab. Rev."},{"key":"2714_CR156","doi-asserted-by":"publisher","first-page":"9734738","DOI":"10.1155\/2022\/9734738","volume":"2022","author":"W Gu","year":"2022","unstructured":"Gu, W. et al. Effects of resveratrol on metabolic indicators in patients with type 2 diabetes: a systematic review and meta-analysis. Int. J. Clin. Pract. 2022, 9734738 (2022).","journal-title":"Int. J. Clin. Pract."},{"key":"2714_CR157","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1038\/nm.4222","volume":"22","author":"T Eisenberg","year":"2016","unstructured":"Eisenberg, T. et al. Cardioprotection and lifespan extension by the natural polyamine spermidine. Nat. Med. 22, 1428\u20131438 (2016).","journal-title":"Nat. Med."},{"key":"2714_CR158","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2023.159425","volume":"1869","author":"C Bian","year":"2024","unstructured":"Bian, C. et al. Docosahexaenoic acid (DHA) inhibits abdominal fat accumulation by promoting adipocyte apoptosis through PPAR\u03b3-LC3-BNIP3 pathway-mediated mitophagy. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1869, 159425 (2024).","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"2714_CR159","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2023.109644","volume":"743","author":"Q Du","year":"2023","unstructured":"Du, Q. et al. Silibinin alleviates ferroptosis of rat islet \u03b2 cell INS-1 induced by the treatment with palmitic acid and high glucose through enhancing PINK1\/parkin-mediated mitophagy. Arch. Biochem. Biophys. 743, 109644 (2023).","journal-title":"Arch. Biochem. Biophys."},{"key":"2714_CR160","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jphs.2017.11.007","volume":"136","author":"LL Gong","year":"2018","unstructured":"Gong, L. L. et al. Akebia saponin D alleviates hepatic steatosis through BNip3 induced mitophagy. J. Pharmacol. Sci. 136, 189\u2013195 (2018).","journal-title":"J. Pharmacol. Sci."},{"key":"2714_CR161","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.201800164","volume":"62","author":"P Liu","year":"2018","unstructured":"Liu, P. et al. Frataxin-mediated PINK1-parkin-dependent mitophagy in hepatic steatosis: the protective effects of quercetin. Mol. Nutr. Food Res. 62, e1800164 (2018).","journal-title":"Mol. Nutr. Food Res."},{"key":"2714_CR162","doi-asserted-by":"publisher","first-page":"114933","DOI":"10.1016\/j.bcp.2022.114933","volume":"197","author":"H-Y Li","year":"2022","unstructured":"Li, H.-Y. & Peng, Z.-G. Targeting lipophagy as a potential therapeutic strategy for nonalcoholic fatty liver disease. Biochem. Pharmacol. 197, 114933 (2022).","journal-title":"Biochem. Pharmacol."},{"key":"2714_CR163","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2019.172715","volume":"864","author":"X Yu","year":"2019","unstructured":"Yu, X. et al. Liraglutide ameliorates non-alcoholic steatohepatitis by inhibiting NLRP3 inflammasome and pyroptosis activation via mitophagy. Eur. J. Pharmacol. 864, 172715 (2019).","journal-title":"Eur. J. Pharmacol."},{"key":"2714_CR164","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.13651","volume":"6","author":"N Brandt","year":"2018","unstructured":"Brandt, N., Gunnarsson, T. P., Bangsbo, J. & Pilegaard, H. Exercise and exercise training-induced increase in autophagy markers in human skeletal muscle. Physiol. Rep. 6, e13651 (2018).","journal-title":"Physiol. Rep."},{"key":"2714_CR165","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s11739-024-03700-w","volume":"19","author":"P Jakubek","year":"2024","unstructured":"Jakubek, P. et al. Autophagy alterations in obesity, type 2 diabetes, and metabolic dysfunction-associated steatotic liver disease: the evidence from human studies. Intern. Emerg. Med. 19, 1473\u20131491 (2024).","journal-title":"Intern. Emerg. Med."},{"key":"2714_CR166","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.cmet.2022.12.001","volume":"35","author":"M Ezpeleta","year":"2023","unstructured":"Ezpeleta, M. et al. Effect of alternate day fasting combined with aerobic exercise on non-alcoholic fatty liver disease: a randomized controlled trial. Cell Metab. 35, 56\u201370.e53 (2023).","journal-title":"Cell Metab."},{"key":"2714_CR167","doi-asserted-by":"publisher","first-page":"1339128","DOI":"10.3389\/fphys.2024.1339128","volume":"15","author":"S Tang","year":"2024","unstructured":"Tang, S., Geng, Y. & Lin, Q. The role of mitophagy in metabolic diseases and its exercise intervention. Front. Physiol. 15, 1339128 (2024).","journal-title":"Front. Physiol."},{"key":"2714_CR168","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.molcel.2019.09.009","volume":"76","author":"D Takahashi","year":"2019","unstructured":"Takahashi, D. et al. AUTACs: cargo-specific degraders using selective autophagy. Mol. Cell. 76, 797\u2013810.e710 (2019).","journal-title":"Mol. Cell."},{"key":"2714_CR169","first-page":"1","volume":"50","author":"JS Park","year":"2018","unstructured":"Park, J. S. et al. An MG53-IRS1-interaction disruptor ameliorates insulin resistance. Exp. Mol. Med. 50, 1\u201312 (2018).","journal-title":"Exp. Mol. Med."},{"key":"2714_CR170","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.106771","volume":"26","author":"M Francis","year":"2023","unstructured":"Francis, M. et al. Deubiquitinase USP1 influences the dedifferentiation of mouse pancreatic \u03b2-cells. iScience 26, 106771 (2023).","journal-title":"iScience"},{"key":"2714_CR171","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.isci.2018.02.003","volume":"1","author":"KDD Gorrepati","year":"2018","unstructured":"Gorrepati, K. D. D. et al. Loss of deubiquitinase USP1 blocks pancreatic \u03b2-cell apoptosis by inhibiting DNA damage response. iScience 1, 72\u201386 (2018).","journal-title":"iScience"},{"key":"2714_CR172","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41392-022-00999-9","volume":"7","author":"M He","year":"2022","unstructured":"He, M. et al. PROTACs: great opportunities for academia and industry (an update from 2020 to 2021). Signal Transduct. Target Ther. 7, 181 (2022).","journal-title":"Signal Transduct. Target Ther."},{"key":"2714_CR173","doi-asserted-by":"publisher","first-page":"4908","DOI":"10.1021\/acs.jmedchem.0c00339","volume":"63","author":"M-X Li","year":"2020","unstructured":"Li, M.-X. et al. Degradation versus Inhibition: development of proteolysis-targeting chimeras for overcoming statin-induced compensatory upregulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase. J. Med. Chem. 63, 4908\u20134928 (2020).","journal-title":"J. Med. Chem."},{"key":"2714_CR174","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106627","volume":"188","author":"Q-Q Zhou","year":"2023","unstructured":"Zhou, Q.-Q. et al. Advancing targeted protein degradation for metabolic diseases therapy. Pharmacol. Res. 188, 106627 (2023).","journal-title":"Pharmacol. Res."},{"key":"2714_CR175","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1126\/science.1128294","volume":"313","author":"U \u00d6zcan","year":"2006","unstructured":"\u00d6zcan, U. et al. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 313, 1137\u20131140 (2006).","journal-title":"Science"},{"key":"2714_CR176","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41573-021-00320-3","volume":"21","author":"SJ Marciniak","year":"2022","unstructured":"Marciniak, S. J., Chambers, J. E. & Ron, D. Pharmacological targeting of endoplasmic reticulum stress in disease. Nat. Rev. Drug Discov. 21, 115\u2013140 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2714_CR177","doi-asserted-by":"publisher","first-page":"423","DOI":"10.2174\/13894501113146660230","volume":"15","author":"J Acunzo","year":"2014","unstructured":"Acunzo, J. et al. Hsp27 as a therapeutic target in cancers. Curr. Drug Targets 15, 423\u2013431 (2014).","journal-title":"Curr. Drug Targets"},{"key":"2714_CR178","doi-asserted-by":"publisher","first-page":"E496","DOI":"10.1002\/ijc.29122","volume":"136","author":"T Cordonnier","year":"2015","unstructured":"Cordonnier, T. et al. Hsp27 regulates EGF\/\u03b2-catenin mediated epithelial to mesenchymal transition in prostate cancer. Int. J. Cancer 136, E496\u2013E507 (2015).","journal-title":"Int. J. Cancer"},{"key":"2714_CR179","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1245\/s10434-018-07149-y","volume":"26","author":"Y Uno","year":"2019","unstructured":"Uno, Y. et al. Increased expression of DNAJC12 is associated with aggressive phenotype of gastric cancer. Ann. Surg. Oncol. 26, 836\u2013844 (2019).","journal-title":"Ann. Surg. Oncol."},{"key":"2714_CR180","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1016\/j.bbamcr.2015.07.024","volume":"1853","author":"S-Y Park","year":"2015","unstructured":"Park, S.-Y. et al. DNAJB1 negatively regulates MIG6 to promote epidermal growth factor receptor signaling. Biochim. Biophys. Acta 1853, 2722\u20132730 (2015).","journal-title":"Biochim. Biophys. Acta"},{"key":"2714_CR181","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41388-019-0978-0","volume":"39","author":"S Yang","year":"2020","unstructured":"Yang, S. et al. KNK437 restricts the growth and metastasis of colorectal cancer via targeting DNAJA1\/CDC45 axis. Oncogene 39, 249\u2013261 (2020).","journal-title":"Oncogene"},{"key":"2714_CR182","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41392-025-02439-w","volume":"10","author":"OF Kuzu","year":"2025","unstructured":"Kuzu, O. F., Granerud, L. J. T. & Saatcioglu, F. Navigating the landscape of protein folding and proteostasis: from molecular chaperones to therapeutic innovations. Signal Transduct. Target Ther. 10, 358 (2025).","journal-title":"Signal Transduct. Target Ther."},{"key":"2714_CR183","doi-asserted-by":"publisher","first-page":"4785","DOI":"10.1158\/0008-5472.CAN-16-3233","volume":"77","author":"J Sampson","year":"2017","unstructured":"Sampson, J. et al. Hsp72 and Nek6 cooperate to cluster amplified centrosomes in cancer cells. Cancer Res 77, 4785\u20134796 (2017).","journal-title":"Cancer Res"},{"key":"2714_CR184","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-016-0425-9","volume":"35","author":"N Jagadish","year":"2016","unstructured":"Jagadish, N. et al. Heat shock protein 70-2 (HSP70-2) overexpression in breast cancer. J. Exp. Clin. Cancer Res. 35, 1\u201314 (2016).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2714_CR185","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1749-6632.2010.05196.x","volume":"1197","author":"M Sherman","year":"2010","unstructured":"Sherman, M. Major heat shock protein Hsp72 controls oncogene-induced senescence. Ann. N. Y. Acad. Sci. 1197, 152\u2013157 (2010).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"2714_CR186","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13014-019-1286-0","volume":"14","author":"A Rothammer","year":"2019","unstructured":"Rothammer, A. et al. Increased heat shock protein 70 (Hsp70) serum levels and low NK cell counts after radiotherapy\u2013potential markers for predicting breast cancer recurrence? Radiat. Oncol. 14, 1\u20139 (2019).","journal-title":"Radiat. Oncol."},{"key":"2714_CR187","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1491-7","volume":"10","author":"P Martine","year":"2019","unstructured":"Martine, P. et al. HSP70 is a negative regulator of NLRP3 inflammasome activation. Cell Death Dis. 10, 256 (2019).","journal-title":"Cell Death Dis."},{"key":"2714_CR188","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3390\/cells9010060","volume":"9","author":"CW Yun","year":"2019","unstructured":"Yun, C. W., Kim, H. J., Lim, J. H. & Lee, S. H. Heat shock proteins: agents of cancer development and therapeutic targets in anti-cancer therapy. Cells 9, 60 (2019).","journal-title":"Cells"},{"key":"2714_CR189","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1158\/1535-7163.MCT-15-0069","volume":"14","author":"T Shirota","year":"2015","unstructured":"Shirota, T. et al. Heat shock protein 90 is a potential therapeutic target in cholangiocarcinoma. Mol. Cancer Ther. 14, 1985\u20131993 (2015).","journal-title":"Mol. Cancer Ther."},{"key":"2714_CR190","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/1440-1681.13613","volume":"49","author":"ZP Yao","year":"2022","unstructured":"Yao, Z. P., Zhu, H., Shen, F. & Gong, D. Hsp90 regulates the tumorigenic function of tyrosine protein kinase in osteosarcoma. Clin. Exp. Pharmacol. Physiol. 49, 380\u2013390 (2022).","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"2714_CR191","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1002\/mc.22185","volume":"54","author":"GP Nagaraju","year":"2015","unstructured":"Nagaraju, G. P. et al. Heat shock protein 90 promotes epithelial to mesenchymal transition, invasion, and migration in colorectal cancer. Mol. Carcinog. 54, 1147\u20131158 (2015).","journal-title":"Mol. Carcinog."},{"key":"2714_CR192","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-017-0640-9","volume":"16","author":"J Meng","year":"2017","unstructured":"Meng, J. et al. Hsp90\u03b2 promoted endothelial cell-dependent tumor angiogenesis in hepatocellular carcinoma. Mol. Cancer 16, 1\u201311 (2017).","journal-title":"Mol. Cancer"},{"key":"2714_CR193","doi-asserted-by":"publisher","first-page":"8711","DOI":"10.1074\/jbc.H119.009180","volume":"294","author":"AH Tien","year":"2019","unstructured":"Tien, A. H. & Sadar, M. D. Keys to unlock androgen receptor translocation. J. Biol. Chem. 294, 8711\u20138712 (2019).","journal-title":"J. Biol. Chem."},{"key":"2714_CR194","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/j.1432-1033.1996.0653p.x","volume":"237","author":"C Garrido","year":"1996","unstructured":"Garrido, C. et al. Inconstant association between 27-kDa heat-shock protein (Hsp27) content and doxorubicin resistance in human colon cancer cells: the doxorubicin-protecting effect of Hsp27. Eur. J. Biochem. 237, 653\u2013659 (1996).","journal-title":"Eur. J. Biochem."},{"key":"2714_CR195","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3390\/biomedicines10040897","volume":"10","author":"M Lampros","year":"2022","unstructured":"Lampros, M., Vlachos, N., Voulgaris, S. & Alexiou, G. A. The role of Hsp27 in chemotherapy resistance. Biomedicines 10, 897 (2022).","journal-title":"Biomedicines"},{"key":"2714_CR196","first-page":"4258","volume":"61","author":"V Shridhar","year":"2001","unstructured":"Shridhar, V. et al. Loss of expression of a new member of the DNAJ protein family confers resistance to chemotherapeutic agents used in the treatment of ovarian cancer. Cancer Res. 61, 4258\u20134265 (2001).","journal-title":"Cancer Res."},{"key":"2714_CR197","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0304-3835(97)00255-3","volume":"119","author":"M Abu-Hadid","year":"1997","unstructured":"Abu-Hadid, M. et al. Relationship between heat shock protein 60 (HSP60) mRNA expression and resistance to platinum analogues in human ovarian and bladder carcinoma cell lines. Cancer Lett. 119, 63\u201370 (1997).","journal-title":"Cancer Lett."},{"key":"2714_CR198","first-page":"4943","volume":"37","author":"JH Lee","year":"2017","unstructured":"Lee, J. H., Yoon, Y. M. & Lee, S. H. GRP78 regulates apoptosis, cell survival and proliferation in 5-fluorouracil-resistant SNUC5 colon cancer cells. Anticancer Res. 37, 4943\u20134951 (2017).","journal-title":"Anticancer Res."},{"key":"2714_CR199","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.canlet.2013.05.004","volume":"336","author":"L Yang","year":"2013","unstructured":"Yang, L. et al. Inhibition of mortalin expression reverses cisplatin resistance and attenuates growth of ovarian cancer cells. Cancer Lett. 336, 213\u2013221 (2013).","journal-title":"Cancer Lett."},{"key":"2714_CR200","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-018-0880-6","volume":"37","author":"X Xiao","year":"2018","unstructured":"Xiao, X. et al. HSP90AA1-mediated autophagy promotes drug resistance in osteosarcoma. J. Exp. Clin. Cancer Res. 37, 1\u201313 (2018).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2714_CR201","doi-asserted-by":"publisher","first-page":"217571","DOI":"10.1016\/j.canlet.2025.217571","volume":"616","author":"I Skrabalak","year":"2025","unstructured":"Skrabalak, I. et al. Therapy resistance: modulating evolutionarily conserved heat shock protein machinery in cancer. Cancer Lett. 616, 217571 (2025).","journal-title":"Cancer Lett."},{"key":"2714_CR202","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1111\/cas.13238","volume":"108","author":"J Bai","year":"2017","unstructured":"Bai, J. et al. HSP 90 inhibitor AUY 922 can reverse Fulvestrant induced feedback reaction in human breast cancer cells. Cancer Sci. 108, 1177\u20131184 (2017).","journal-title":"Cancer Sci."},{"key":"2714_CR203","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s12032-007-9020-4","volume":"25","author":"J Ishibashi","year":"2008","unstructured":"Ishibashi, J. et al. The effects inhibiting the proliferation of cancer cells by far-infrared radiation (FIR) are controlled by the basal expression level of heat shock protein (HSP) 70A. Med. Oncol. 25, 229\u2013237 (2008).","journal-title":"Med. Oncol."},{"key":"2714_CR204","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.radonc.2018.05.021","volume":"128","author":"M Yao","year":"2018","unstructured":"Yao, M. et al. Sensitization of prostate cancer to radiation therapy: molecules and pathways to target. Radiother. Oncol. 128, 283\u2013300 (2018).","journal-title":"Radiother. Oncol."},{"key":"2714_CR205","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.cell.2009.03.048","volume":"137","author":"R Mathew","year":"2009","unstructured":"Mathew, R. et al. Autophagy suppresses tumorigenesis through elimination of p62. Cell 137, 1062\u20131075 (2009).","journal-title":"Cell"},{"key":"2714_CR206","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1172\/JCI20039","volume":"112","author":"X Qu","year":"2003","unstructured":"Qu, X. et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J. Clin. Invest. 112, 1809\u20131820 (2003).","journal-title":"J. Clin. Invest."},{"key":"2714_CR207","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1101\/gad.2016211","volume":"25","author":"A Takamura","year":"2011","unstructured":"Takamura, A. et al. Autophagy-deficient mice develop multiple liver tumors. Genes Dev. 25, 795\u2013800 (2011).","journal-title":"Genes Dev."},{"key":"2714_CR208","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12929-023-00956-w","volume":"30","author":"SF Wang","year":"2023","unstructured":"Wang, S. F., Tseng, L. M. & Lee, H. C. Role of mitochondrial alterations in human cancer progression and cancer immunity. J. Biomed. Sci. 30, 61 (2023).","journal-title":"J. Biomed. Sci."},{"key":"2714_CR209","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1093\/hmg\/ddt533","volume":"23","author":"L Iommarini","year":"2014","unstructured":"Iommarini, L. et al. Different mtDNA mutations modify tumor progression in dependence of the degree of respiratory complex I impairment. Hum. Mol. Genet. 23, 1453\u20131466 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"2714_CR210","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nature02517","volume":"429","author":"A Trifunovic","year":"2004","unstructured":"Trifunovic, A. et al. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 429, 417\u2013423 (2004).","journal-title":"Nature"},{"key":"2714_CR211","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1158\/0008-5472.CAN-07-5532","volume":"68","author":"S Dasgupta","year":"2008","unstructured":"Dasgupta, S., Hoque, M. O., Upadhyay, S. & Sidransky, D. Mitochondrial cytochrome B gene mutation promotes tumor growth in bladder cancer. Cancer Res. 68, 700\u2013706 (2008).","journal-title":"Cancer Res."},{"key":"2714_CR212","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1158\/1055-9965.EPI-10-1224","volume":"20","author":"J Permuth-Wey","year":"2011","unstructured":"Permuth-Wey, J. et al. Inherited variants in mitochondrial biogenesis genes may influence epithelial ovarian cancer risk. Cancer Epidemiol. Biomark. Prev. 20, 1131\u20131145 (2011).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"2714_CR213","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/s41588-019-0557-x","volume":"52","author":"Y Yuan","year":"2020","unstructured":"Yuan, Y. et al. Comprehensive molecular characterization of mitochondrial genomes in human cancers. Nat. Genet. 52, 342\u2013352 (2020).","journal-title":"Nat. Genet."},{"key":"2714_CR214","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1016\/S0002-9440(10)61132-7","volume":"160","author":"V M\u00e1ximo","year":"2002","unstructured":"M\u00e1ximo, V. et al. Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on H\u00fcrthle cell tumors. Am. J. Pathol. 160, 1857\u20131865 (2002).","journal-title":"Am. J. Pathol."},{"key":"2714_CR215","first-page":"1299","volume":"61","author":"JB Jones","year":"2001","unstructured":"Jones, J. B. et al. Detection of mitochondrial DNA mutations in pancreatic cancer offers a \u201cmass\u201d-ive advantage over detection of nuclear DNA mutations. Cancer Res. 61, 1299\u20131304 (2001).","journal-title":"Cancer Res."},{"key":"2714_CR216","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s42255-021-00378-8","volume":"3","author":"AN Gorelick","year":"2021","unstructured":"Gorelick, A. N. et al. Respiratory complex and tissue lineage drive recurrent mutations in tumour mtDNA. Nat. Metab. 3, 558\u2013570 (2021).","journal-title":"Nat. Metab."},{"key":"2714_CR217","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ccr.2006.06.001","volume":"10","author":"K Degenhardt","year":"2006","unstructured":"Degenhardt, K. et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 10, 51\u201364 (2006).","journal-title":"Cancer Cell"},{"key":"2714_CR218","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1126\/science.1193497","volume":"330","author":"JD Rabinowitz","year":"2010","unstructured":"Rabinowitz, J. D. & White, E. Autophagy and metabolism. Science 330, 1344\u20131348 (2010).","journal-title":"Science"},{"key":"2714_CR219","first-page":"3917","volume":"118","author":"Z Lu","year":"2008","unstructured":"Lu, Z. et al. The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells. J. Clin. Invest. 118, 3917\u20133929 (2008).","journal-title":"J. Clin. Invest."},{"key":"2714_CR220","doi-asserted-by":"publisher","first-page":"166400","DOI":"10.1016\/j.bbadis.2022.166400","volume":"1868","author":"R Rakesh","year":"2022","unstructured":"Rakesh, R., PriyaDharshini, L. C., Sakthivel, K. M. & Rasmi, R. R. Role and regulation of autophagy in cancer. Biochim. Biophys. Acta 1868, 166400 (2022).","journal-title":"Biochim. Biophys. Acta"},{"key":"2714_CR221","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/cdd.2009.16","volume":"16","author":"J Zhang","year":"2009","unstructured":"Zhang, J. & Ney, P. A. Role of BNIP3 and NIX in cell death, autophagy, and mitophagy. Cell Death Differ. 16, 939\u2013946 (2009).","journal-title":"Cell Death Differ."},{"key":"2714_CR222","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/biolre\/ioy061","volume":"99","author":"J Zhou","year":"2018","unstructured":"Zhou, J. et al. Hypoxia-inducible factor-1\u03b1-dependent autophagy plays a role in glycolysis switch in mouse granulosa cells. Biol. Reprod. 99, 308\u2013318 (2018).","journal-title":"Biol. Reprod."},{"key":"2714_CR223","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1593\/neo.08586","volume":"10","author":"A Schneider","year":"2008","unstructured":"Schneider, A., Younis, R. H. & Gutkind, J. S. Hypoxia-induced energy stress inhibits the mTOR pathway by activating an AMPK\/REDD1 signaling axis in head and neck squamous cell carcinoma. Neoplasia 10, 1295\u20131302 (2008).","journal-title":"Neoplasia"},{"key":"2714_CR224","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1126\/science.aar2663","volume":"360","author":"GA Wyant","year":"2018","unstructured":"Wyant, G. A. et al. NUFIP1 is a ribosome receptor for starvation-induced ribophagy. Science 360, 751\u2013758 (2018).","journal-title":"Science"},{"key":"2714_CR225","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41556-024-01598-2","volume":"27","author":"Y Chen","year":"2025","unstructured":"Chen, Y. et al. Rpl12 is a conserved ribophagy receptor. Nat. Cell Biol. 27, 477\u2013492 (2025).","journal-title":"Nat. Cell Biol."},{"key":"2714_CR226","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1111\/febs.14932","volume":"286","author":"S Wilkinson","year":"2019","unstructured":"Wilkinson, S. ER-phagy: shaping up and destressing the endoplasmic reticulum. FEBS J. 286, 2645\u20132663 (2019).","journal-title":"FEBS J."},{"key":"2714_CR227","doi-asserted-by":"publisher","first-page":"222","DOI":"10.7150\/thno.49860","volume":"11","author":"W Li","year":"2021","unstructured":"Li, W. et al. Selective autophagy of intracellular organelles: recent research advances. Theranostics 11, 222 (2021).","journal-title":"Theranostics"},{"key":"2714_CR228","doi-asserted-by":"publisher","first-page":"5956","DOI":"10.1073\/pnas.0931262100","volume":"100","author":"R Cesari","year":"2003","unstructured":"Cesari, R. et al. Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25\u2013q27. Proc. Natl. Acad. Sci. USA 100, 5956\u20135961 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2714_CR229","doi-asserted-by":"publisher","first-page":"6002","DOI":"10.1038\/onc.2008.199","volume":"27","author":"M Fujiwara","year":"2008","unstructured":"Fujiwara, M. et al. Parkin as a tumor suppressor gene for hepatocellular carcinoma. Oncogene 27, 6002\u20136011 (2008).","journal-title":"Oncogene"},{"key":"2714_CR230","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.devcel.2018.07.012","volume":"46","author":"C Li","year":"2018","unstructured":"Li, C. et al. PINK1 and PARK2 suppress pancreatic tumorigenesis through control of mitochondrial iron-mediated immunometabolism. Dev. Cell. 46, 441\u2013455.e448 (2018).","journal-title":"Dev. Cell."},{"key":"2714_CR231","doi-asserted-by":"publisher","first-page":"4708","DOI":"10.1158\/0008-5472.CAN-15-3079","volume":"76","author":"S Agnihotri","year":"2016","unstructured":"Agnihotri, S. et al. PINK1 is a negative regulator of growth and the Warburg effect in glioblastoma. Cancer Res. 76, 4708\u20134719 (2016).","journal-title":"Cancer Res."},{"key":"2714_CR232","doi-asserted-by":"publisher","first-page":"4037","DOI":"10.1111\/cas.15568","volume":"113","author":"M Wang","year":"2022","unstructured":"Wang, M. et al. The emerging multifaceted role of PINK1 in cancer biology. Cancer Sci. 113, 4037\u20134047 (2022).","journal-title":"Cancer Sci."},{"key":"2714_CR233","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1002\/1878-0261.13578","volume":"18","author":"Z Wu","year":"2024","unstructured":"Wu, Z. et al. Mitochondrial fusion\u2013fission dynamics and its involvement in colorectal cancer. Mol. Oncol. 18, 1058\u20131075 (2024).","journal-title":"Mol. Oncol."},{"key":"2714_CR234","doi-asserted-by":"publisher","first-page":"3305","DOI":"10.1074\/jbc.275.5.3305","volume":"275","author":"SJ Felts","year":"2000","unstructured":"Felts, S. J. et al. The hsp90-related protein TRAP1 is a mitochondrial protein with distinct functional properties. J. Biol. Chem. 275, 3305\u20133312 (2000).","journal-title":"J. Biol. Chem."},{"key":"2714_CR235","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3139","volume":"4","author":"YC Chae","year":"2013","unstructured":"Chae, Y. C. et al. Landscape of the mitochondrial Hsp90 metabolome in tumours. Nat. Commun. 4, 2139 (2013).","journal-title":"Nat. Commun."},{"key":"2714_CR236","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.cmet.2013.04.019","volume":"17","author":"M Sciacovelli","year":"2013","unstructured":"Sciacovelli, M. et al. The mitochondrial chaperone TRAP1 promotes neoplastic growth by inhibiting succinate dehydrogenase. Cell Metab. 17, 988\u2013999 (2013).","journal-title":"Cell Metab."},{"key":"2714_CR237","doi-asserted-by":"publisher","first-page":"E1604","DOI":"10.1073\/pnas.1220659110","volume":"110","author":"S Yoshida","year":"2013","unstructured":"Yoshida, S. et al. Molecular chaperone TRAP1 regulates a metabolic switch between mitochondrial respiration and aerobic glycolysis. Proc. Natl. Acad. Sci. USA 110, E1604\u2013E1612 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2714_CR238","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1146\/annurev-biophys-121219-081604","volume":"49","author":"L Ruan","year":"2020","unstructured":"Ruan, L. et al. Mitochondria-associated proteostasis. Ann. Rev. Biophys. 49, 41\u201367 (2020).","journal-title":"Ann. Rev. Biophys."},{"key":"2714_CR239","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1172\/JCI35660","volume":"119","author":"C Bellodi","year":"2009","unstructured":"Bellodi, C. et al. Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells. J. Clin. Invest. 119, 1109\u20131123 (2009).","journal-title":"J. Clin. Invest."},{"key":"2714_CR240","doi-asserted-by":"publisher","first-page":"3622","DOI":"10.1182\/blood-2013-07-516807","volume":"123","author":"K Rothe","year":"2014","unstructured":"Rothe, K. et al. The core autophagy protein ATG4B is a potential biomarker and therapeutic target in CML stem\/progenitor cells. Blood 123, 3622\u20133634 (2014).","journal-title":"Blood"},{"key":"2714_CR241","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0864-7","volume":"9","author":"M Buccarelli","year":"2018","unstructured":"Buccarelli, M. et al. Inhibition of autophagy increases susceptibility of glioblastoma stem cells to temozolomide by igniting ferroptosis. Cell Death Dis. 9, 841 (2018).","journal-title":"Cell Death Dis."},{"key":"2714_CR242","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1073\/pnas.88.1.139","volume":"88","author":"A Ciechanover","year":"1991","unstructured":"Ciechanover, A. et al. Degradation of nuclear oncoproteins by the ubiquitin system in vitro. Proc. Natl. Acad. Sci. USA 88, 139\u2013143 (1991).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2714_CR243","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/j.1365-2133.2007.08390.x","volume":"158","author":"A Sorolla","year":"2008","unstructured":"Sorolla, A. et al. Effect of proteasome inhibitors on proliferation and apoptosis of human cutaneous melanoma-derived cell lines. Br. J. Dermatol. 158, 496\u2013504 (2008).","journal-title":"Br. J. Dermatol."},{"key":"2714_CR244","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cell.2009.01.039","volume":"137","author":"M Adorno","year":"2009","unstructured":"Adorno, M. et al. A mutant-p53\/Smad complex opposes p63 to empower TGF\u03b2-induced metastasis. Cell 137, 87\u201398 (2009).","journal-title":"Cell"},{"key":"2714_CR245","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1083\/jcb.200804107","volume":"182","author":"M Kowanetz","year":"2008","unstructured":"Kowanetz, M. et al. TGF\u03b2 induces SIK to negatively regulate type I receptor kinase signaling. J. Cell Biol. 182, 655\u2013662 (2008).","journal-title":"J. Cell Biol."},{"key":"2714_CR246","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1111\/j.1349-7006.2008.00925.x","volume":"99","author":"Y Inoue","year":"2008","unstructured":"Inoue, Y. & Imamura, T. Regulation of TGF-\u03b2 family signaling by E3 ubiquitin ligases. Cancer Sci. 99, 2107\u20132112 (2008).","journal-title":"Cancer Sci."},{"key":"2714_CR247","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.molcel.2004.07.021","volume":"15","author":"Y Bai","year":"2004","unstructured":"Bai, Y. et al. Itch E3 ligase-mediated regulation of TGF-\u03b2 signaling by modulating smad2 phosphorylation. Mol. Cell. 15, 825\u2013831 (2004).","journal-title":"Mol. Cell."},{"key":"2714_CR248","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.canlet.2006.01.003","volume":"245","author":"W Qiu","year":"2007","unstructured":"Qiu, W., Sch\u00f6nleben, F., Li, X. & Su, G. H. Disruption of transforming growth factor \u03b2-Smad signaling pathway in head and neck squamous cell carcinoma as evidenced by mutations of SMAD2 and SMAD4. Cancer Lett. 245, 163\u2013170 (2007).","journal-title":"Cancer Lett."},{"key":"2714_CR249","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1002\/cam4.1069","volume":"6","author":"J Ma","year":"2017","unstructured":"Ma, J., Guo, W. & Li, C. Ubiquitination in melanoma pathogenesis and treatment. Cancer Med. 6, 1362\u20131377 (2017).","journal-title":"Cancer Med."},{"key":"2714_CR250","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1080\/15384047.2021.1978785","volume":"22","author":"OM El Yaagoubi","year":"2021","unstructured":"El Yaagoubi, O. M. et al. The role of the ubiquitin-proteasome pathway in skin cancer development: 26S proteasome-activated NF-\u03baB signal transduction. Cancer Biol. Ther. 22, 479\u2013492 (2021).","journal-title":"Cancer Biol. Ther."},{"key":"2714_CR251","first-page":"706","volume":"163","author":"W McBride","year":"2005","unstructured":"McBride, W., Iwamoto, K. & Pervan, M. The proteasome and radiation. Radiat. Res. 163, 706\u2013707 (2005).","journal-title":"Radiat. Res."},{"key":"2714_CR252","doi-asserted-by":"publisher","first-page":"5755","DOI":"10.1038\/sj.onc.1206676","volume":"22","author":"WH McBride","year":"2003","unstructured":"McBride, W. H. et al. The role of the ubiquitin\/proteasome system in cellular responses to radiation. Oncogene 22, 5755\u20135773 (2003).","journal-title":"Oncogene"},{"key":"2714_CR253","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.bbadis.2008.06.007","volume":"1782","author":"IA Voutsadakis","year":"2008","unstructured":"Voutsadakis, I. A. The ubiquitin-proteasome system in colorectal cancer. Biochim. Biophys. Acta 1782, 800\u2013808 (2008).","journal-title":"Biochim. Biophys. Acta"},{"key":"2714_CR254","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S0002-9440(10)64856-0","volume":"160","author":"NACS Wong","year":"2002","unstructured":"Wong, N. A. C. S. & Pignatelli, M. \u03b2-catenin\u2014a linchpin in colorectal carcinogenesis? Am. J. Pathol. 160, 389\u2013401 (2002).","journal-title":"Am. J. Pathol."},{"key":"2714_CR255","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S1097-2765(01)00241-6","volume":"7","author":"J Liu","year":"2001","unstructured":"Liu, J. et al. Siah-1 mediates a novel \u03b2-catenin degradation pathway linking p53 to the adenomatous polyposis coli protein. Mol. Cell. 7, 927\u2013936 (2001).","journal-title":"Mol. Cell."},{"key":"2714_CR256","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1101\/gad.10.16.1979","volume":"10","author":"BE Clurman","year":"1996","unstructured":"Clurman, B. E. et al. Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation. Genes Dev. 10, 1979\u20131990 (1996).","journal-title":"Genes Dev."},{"key":"2714_CR257","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/45836","volume":"401","author":"CH Spruck","year":"1999","unstructured":"Spruck, C. H., Won, K.-A. & Reed, S. I. Deregulated cyclin E induces chromosome instability. Nature 401, 297\u2013300 (1999).","journal-title":"Nature"},{"key":"2714_CR258","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/35095076","volume":"413","author":"H Strohmaier","year":"2001","unstructured":"Strohmaier, H. et al. Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line. Nature 413, 316\u2013322 (2001).","journal-title":"Nature"},{"key":"2714_CR259","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1002\/1097-0142(20010501)91:9<1745::AID-CNCR1193>3.0.CO;2-H","volume":"91","author":"D Hershko","year":"2001","unstructured":"Hershko, D. et al. Inverse relation between levels of p27Kip1 and of its ubiquitin ligase subunit Skp2 in colorectal carcinomas. Cancer 91, 1745\u20131751 (2001).","journal-title":"Cancer"},{"key":"2714_CR260","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2020.111876","volume":"388","author":"M Huang","year":"2020","unstructured":"Huang, M. et al. CSN5 upregulates glycolysis to promote hepatocellular carcinoma metastasis via stabilizing the HK2 protein. Exp. Cell Res. 388, 111876 (2020).","journal-title":"Exp. Cell Res."},{"key":"2714_CR261","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1080\/15548627.2017.1381804","volume":"14","author":"L Jiao","year":"2018","unstructured":"Jiao, L. et al. Regulation of glycolytic metabolism by autophagy in liver cancer involves selective autophagic degradation of HK2 (hexokinase 2). Autophagy 14, 671\u2013684 (2018).","journal-title":"Autophagy"},{"key":"2714_CR262","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.3892\/ijo.2015.2901","volume":"46","author":"S-R Kim","year":"2015","unstructured":"Kim, S.-R. et al. Regulation of pyruvate kinase isozyme M2 is mediated by the ubiquitin-specific protease 20. Int. J. Oncol. 46, 2116\u20132124 (2015).","journal-title":"Int. J. Oncol."},{"key":"2714_CR263","doi-asserted-by":"publisher","first-page":"13870","DOI":"10.1073\/pnas.1414358111","volume":"111","author":"X Wu","year":"2014","unstructured":"Wu, X. et al. Ubiquitin-conjugating enzyme Ubc13 controls breast cancer metastasis through a TAK1-p38 MAP kinase cascade. Proc. Natl. Acad. Sci. USA 111, 13870\u201313875 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2714_CR264","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2019.100663","volume":"48","author":"S Narayanan","year":"2020","unstructured":"Narayanan, S. et al. Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance. Drug Resist. Updat. 48, 100663 (2020).","journal-title":"Drug Resist. Updat."},{"key":"2714_CR265","first-page":"4683","volume":"33","author":"Y-P Vandewynckel","year":"2013","unstructured":"Vandewynckel, Y.-P. et al. The paradox of the unfolded protein response in cancer. Anticancer Res. 33, 4683\u20134694 (2013).","journal-title":"Anticancer Res."},{"key":"2714_CR266","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13578-021-00538-z","volume":"11","author":"J Huang","year":"2021","unstructured":"Huang, J. et al. Unfolded protein response in colorectal cancer. Cell Biosci. 11, 1\u201316 (2021).","journal-title":"Cell Biosci."},{"key":"2714_CR267","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1080\/14712598.2020.1677603","volume":"20","author":"T Macarulla","year":"2020","unstructured":"Macarulla, T. et al. The role of PIGF blockade in the treatment of colorectal cancer: overcoming the pitfalls. Expert Opin. Biol. Ther. 20, 15\u201322 (2020).","journal-title":"Expert Opin. Biol. Ther."},{"key":"2714_CR268","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1158\/2159-8290.CD-13-0945","volume":"4","author":"Y-x Feng","year":"2014","unstructured":"Feng, Y. -x et al. Epithelial-to-mesenchymal transition activates PERK\u2013eIF2\u03b1 and sensitizes cells to endoplasmic reticulum stress. Cancer Discov. 4, 702\u2013715 (2014).","journal-title":"Cancer Discov."},{"key":"2714_CR269","doi-asserted-by":"publisher","first-page":"3881","DOI":"10.1038\/onc.2010.153","volume":"29","author":"E Bobrovnikova-Marjon","year":"2010","unstructured":"Bobrovnikova-Marjon, E. et al. PERK promotes cancer cell proliferation and tumor growth by limiting oxidative DNA damage. Oncogene 29, 3881\u20133895 (2010).","journal-title":"Oncogene"},{"key":"2714_CR270","doi-asserted-by":"publisher","first-page":"5860","DOI":"10.1038\/onc.2016.121","volume":"35","author":"A Gupta","year":"2016","unstructured":"Gupta, A. et al. NCOA3 coactivator is a transcriptional target of XBP1 and regulates PERK\u2013eIF2\u03b1\u2013ATF4 signalling in breast cancer. Oncogene 35, 5860\u20135871 (2016).","journal-title":"Oncogene"},{"key":"2714_CR271","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1593\/tlo.08211","volume":"2","author":"L Romero-Ramirez","year":"2009","unstructured":"Romero-Ramirez, L. et al. X box-binding protein 1 regulates angiogenesis in human pancreatic adenocarcinomas. Transl. Oncol. 2, 31\u2013IN32 (2009).","journal-title":"Transl. Oncol."},{"key":"2714_CR272","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1182\/blood-2010-08-303099","volume":"117","author":"I Papandreou","year":"2011","unstructured":"Papandreou, I. et al. Identification of an Ire1alpha endonuclease specific inhibitor with cytotoxic activity against human multiple myeloma. Blood 117, 1311\u20131314 (2011).","journal-title":"Blood"},{"key":"2714_CR273","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1007\/s00432-011-1005-1","volume":"137","author":"J-C Heinrich","year":"2011","unstructured":"Heinrich, J.-C. et al. RP101 (brivudine) binds to heat shock protein HSP27 (HSPB1) and enhances survival in animals and pancreatic cancer patients. J. Cancer Res. Clin. Oncol. 137, 1349\u20131361 (2011).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"2714_CR274","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.chembiol.2017.04.008","volume":"24","author":"K Wiechmann","year":"2017","unstructured":"Wiechmann, K. et al. Mitochondrial chaperonin HSP60 is the apoptosis-related target for myrtucommulone. Cell Chem. Biol. 24, 614\u2013623.e616 (2017).","journal-title":"Cell Chem. Biol."},{"key":"2714_CR275","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1002\/elps.201100462","volume":"33","author":"TR Su","year":"2012","unstructured":"Su, T. R. et al. Proteomic investigation of anti-tumor activities exerted by sinularin against A 2058 melanoma cells. Electrophoresis 33, 1139\u20131152 (2012).","journal-title":"Electrophoresis"},{"key":"2714_CR276","doi-asserted-by":"crossref","unstructured":"Kumar, R. M. et al. Fisetin in cancer: attributes, developmental aspects, and nanotherapeutics. Pharmaceuticals. 16, 196 (2023).","DOI":"10.3390\/ph16020196"},{"key":"2714_CR277","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1007\/s12272-019-01181-6","volume":"42","author":"Y-J Lee","year":"2019","unstructured":"Lee, Y.-J. et al. Pifithrin-\u03bc induces necroptosis through oxidative mitochondrial damage but accompanies epithelial\u2013mesenchymal transition-like phenomenon in malignant mesothelioma cells under lactic acidosis. Arch. Pharm. Res. 42, 890\u2013901 (2019).","journal-title":"Arch. Pharm. Res."},{"key":"2714_CR278","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1016\/j.chembiol.2018.06.010","volume":"25","author":"S-H Park","year":"2018","unstructured":"Park, S.-H., Baek, K.-H., Shin, I. & Shin, I. Subcellular Hsp70 inhibitors promote cancer cell death via different mechanisms. Cell Chem. Biol. 25, 1242\u20131254.e1248 (2018).","journal-title":"Cell Chem. Biol."},{"key":"2714_CR279","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1002\/ijc.32227","volume":"145","author":"GP Nagaraju","year":"2019","unstructured":"Nagaraju, G. P. et al. Inhibition of HSP90 overcomes resistance to chemotherapy and radiotherapy in pancreatic cancer. Int. J. Cancer 145, 1529\u20131537 (2019).","journal-title":"Int. J. Cancer"},{"key":"2714_CR280","doi-asserted-by":"publisher","first-page":"5876","DOI":"10.1158\/1078-0432.CCR-15-2190","volume":"22","author":"Y Wang","year":"2016","unstructured":"Wang, Y. et al. Hsp90 inhibitor ganetespib sensitizes non-small cell lung cancer to radiation but has variable effects with chemoradiation. Clin. Cancer Res. 22, 5876\u20135886 (2016).","journal-title":"Clin. Cancer Res."},{"key":"2714_CR281","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1093\/jrr\/rrw054","volume":"57","author":"HK Li","year":"2016","unstructured":"Li, H. K., Matsumoto, Y., Furusawa, Y. & Kamada, T. PU-H71, a novel Hsp90 inhibitor, as a potential cancer-specific sensitizer to carbon-ion beam therapy. J. Radiat. Res. 57, 572\u2013575 (2016).","journal-title":"J. Radiat. Res."},{"key":"2714_CR282","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.canlet.2017.09.040","volume":"411","author":"H Yang","year":"2017","unstructured":"Yang, H. et al. HSP90 inhibitor (NVP-AUY922) enhances the anti-cancer effect of BCL-2 inhibitor (ABT-737) in small cell lung cancer expressing BCL-2. Cancer Lett. 411, 19\u201326 (2017).","journal-title":"Cancer Lett."},{"key":"2714_CR283","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1172\/JCI28833","volume":"117","author":"RK Amaravadi","year":"2007","unstructured":"Amaravadi, R. K. et al. Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J. Clin. Invest. 117, 326\u2013336 (2007).","journal-title":"J. Clin. Invest."},{"key":"2714_CR284","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s13566-013-0111-x","volume":"2","author":"HB Eldredge","year":"2013","unstructured":"Eldredge, H. B. et al. Concurrent whole brain radiotherapy and short-course chloroquine in patients with brain metastases: a pilot trial. J. Radiat. Oncol. 2, 315\u2013321 (2013).","journal-title":"J. Radiat. Oncol."},{"key":"2714_CR285","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1748-717X-8-209","volume":"8","author":"LL Rojas-Puentes","year":"2013","unstructured":"Rojas-Puentes, L. L. et al. Phase II randomized, double-blind, placebo-controlled study of whole-brain irradiation with concomitant chloroquine for brain metastases. Radiat. Oncol. 8, 1\u20139 (2013).","journal-title":"Radiat. Oncol."},{"key":"2714_CR286","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.4161\/auto.29231","volume":"10","author":"D Mahalingam","year":"2014","unstructured":"Mahalingam, D. et al. Combined autophagy and HDAC inhibition: a phase I safety, tolerability, pharmacokinetic, and pharmacodynamic analysis of hydroxychloroquine in combination with the HDAC inhibitor vorinostat in patients with advanced solid tumors. Autophagy 10, 1403\u20131414 (2014).","journal-title":"Autophagy"},{"key":"2714_CR287","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.4161\/auto.29119","volume":"10","author":"R Rangwala","year":"2014","unstructured":"Rangwala, R. et al. Combined MTOR and autophagy inhibition: phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma. Autophagy 10, 1391\u20131402 (2014).","journal-title":"Autophagy"},{"key":"2714_CR288","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.4161\/auto.29118","volume":"10","author":"R Rangwala","year":"2014","unstructured":"Rangwala, R. et al. Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma. Autophagy 10, 1369\u20131379 (2014).","journal-title":"Autophagy"},{"key":"2714_CR289","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/s41418-019-0474-7","volume":"27","author":"JM Mulcahy Levy","year":"2020","unstructured":"Mulcahy Levy, J. M. & Thorburn, A. Autophagy in cancer: moving from understanding mechanism to improving therapy responses in patients. Cell Death Differ. 27, 843\u2013857 (2020).","journal-title":"Cell Death Differ."},{"key":"2714_CR290","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12950-025-00456-8","volume":"22","author":"B Niemann","year":"2025","unstructured":"Niemann, B. et al. Hydroxychloroquine reduces metastatic tumor burden in pancreatic adenocarcinoma through myeloperoxidase inhibition. J. Inflamm. 22, 33 (2025).","journal-title":"J. Inflamm."},{"key":"2714_CR291","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1097\/JTO.0b013e318262de4a","volume":"7","author":"SB Goldberg","year":"2012","unstructured":"Goldberg, S. B. et al. A phase I study of erlotinib and hydroxychloroquine in advanced non\u2013small-cell lung cancer. J. Thorac. Oncol. 7, 1602\u20131608 (2012).","journal-title":"J. Thorac. Oncol."},{"key":"2714_CR292","doi-asserted-by":"publisher","first-page":"200","DOI":"10.4161\/auto.8.2.18554","volume":"8","author":"P Maycotte","year":"2012","unstructured":"Maycotte, P. et al. Chloroquine sensitizes breast cancer cells to chemotherapy independent of autophagy. Autophagy 8, 200\u2013212 (2012).","journal-title":"Autophagy"},{"key":"2714_CR293","doi-asserted-by":"publisher","first-page":"4518","DOI":"10.1038\/onc.2015.511","volume":"35","author":"M King","year":"2016","unstructured":"King, M., Ganley, I. & Flemington, V. Inhibition of cholesterol metabolism underlies synergy between mTOR pathway inhibition and chloroquine in bladder cancer cells. Oncogene 35, 4518\u20134528 (2016).","journal-title":"Oncogene"},{"key":"2714_CR294","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.molcel.2015.05.031","volume":"59","author":"DF Egan","year":"2015","unstructured":"Egan, D. F. et al. Small molecule inhibition of the autophagy kinase ULK1 and identification of ULK1 substrates. Mol. Cell. 59, 285\u2013297 (2015).","journal-title":"Mol. Cell."},{"key":"2714_CR295","doi-asserted-by":"publisher","first-page":"8874","DOI":"10.1074\/jbc.RA118.003547","volume":"293","author":"TA Dite","year":"2018","unstructured":"Dite, T. A. et al. AMP-activated protein kinase selectively inhibited by the type II inhibitor SBI-0206965. J. Biol. Chem. 293, 8874\u20138885 (2018).","journal-title":"J. Biol. Chem."},{"key":"2714_CR296","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13578-021-00575-8","volume":"11","author":"Y Zheng","year":"2021","unstructured":"Zheng, Y. et al. Glioblastoma stem cell (GSC)-derived PD-L1-containing exosomes activates AMPK\/ULK1 pathway mediated autophagy to increase temozolomide-resistance in glioblastoma. Cell Biosci. 11, 1\u201312 (2021).","journal-title":"Cell Biosci."},{"key":"2714_CR297","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ebiom.2018.07.034","volume":"34","author":"J Lu","year":"2018","unstructured":"Lu, J. et al. Overexpression of ULK1 represents a potential diagnostic marker for clear cell renal carcinoma and the antitumor effects of SBI-0206965. EBioMedicine 34, 85\u201393 (2018).","journal-title":"EBioMedicine"},{"key":"2714_CR298","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.canlet.2018.07.028","volume":"435","author":"M Dyczynski","year":"2018","unstructured":"Dyczynski, M. et al. Targeting autophagy by small molecule inhibitors of vacuolar protein sorting 34 (Vps34) improves the sensitivity of breast cancer cells to Sunitinib. Cancer Lett. 435, 32\u201343 (2018).","journal-title":"Cancer Lett."},{"key":"2714_CR299","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.bcp.2018.02.007","volume":"153","author":"M Russo","year":"2018","unstructured":"Russo, M. & Russo, G. L. Autophagy inducers in cancer. Biochem. Pharmacol. 153, 51\u201361 (2018).","journal-title":"Biochem. Pharmacol."},{"key":"2714_CR300","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3816\/CLML.2010.n.059","volume":"10","author":"SA Parikh","year":"2010","unstructured":"Parikh, S. A. et al. Phase II study of obatoclax mesylate (GX15-070), a small-molecule BCL-2 family antagonist, for patients with myelofibrosis. Clin. Lymphoma Myeloma Leuk. 10, 285\u2013289 (2010).","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"2714_CR301","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-2081-4","volume":"10","author":"M Kleih","year":"2019","unstructured":"Kleih, M. et al. Direct impact of cisplatin on mitochondria induces ROS production that dictates cell fate of ovarian cancer cells. Cell Death Dis. 10, 851 (2019).","journal-title":"Cell Death Dis."},{"key":"2714_CR302","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11626-017-0200-z","volume":"54","author":"L Chen","year":"2018","unstructured":"Chen, L., Liu, L., Li, Y. & Gao, J. Melatonin increases human cervical cancer HeLa cells apoptosis induced by cisplatin via inhibition of JNK\/Parkin\/mitophagy axis. Vitr. Cell. Dev. Biol. Anim. 54, 1\u201310 (2018).","journal-title":"Vitr. Cell. Dev. Biol. Anim."},{"key":"2714_CR303","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s12672-021-00454-1","volume":"12","author":"TV Denisenko","year":"2021","unstructured":"Denisenko, T. V., Gogvadze, V. & Zhivotovsky, B. Mitophagy in carcinogenesis and cancer treatment. Discov. Oncol. 12, 58 (2021).","journal-title":"Discov. Oncol."},{"key":"2714_CR304","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/s41591-018-0052-4","volume":"24","author":"JR Molina","year":"2018","unstructured":"Molina, J. R. et al. An inhibitor of oxidative phosphorylation exploits cancer vulnerability. Nat. Med. 24, 1036\u20131046 (2018).","journal-title":"Nat. Med."},{"key":"2714_CR305","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1158\/2159-8290.CD-16-0441","volume":"7","author":"T Farge","year":"2017","unstructured":"Farge, T. et al. Chemotherapy-resistant human acute myeloid leukemia cells are not enriched for leukemic stem cells but require oxidative metabolism. Cancer Discov. 7, 716\u2013735 (2017).","journal-title":"Cancer Discov."},{"key":"2714_CR306","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.medj.2022.01.005","volume":"3","author":"MD Radyk","year":"2022","unstructured":"Radyk, M. D., Kerk, S. A. & Lyssiotis, C. A. Ketotherapy: cutting carbs to treat cancer. Med 3, 87\u201389 (2022).","journal-title":"Med"},{"key":"2714_CR307","doi-asserted-by":"crossref","unstructured":"Schwartz, L. et al. Out of Warburg effect: An effective cancer treatment targeting the tumor specific metabolism and dysregulated pH. Semin Cancer Biol. 43 134\u2013138 (2017).","DOI":"10.1016\/j.semcancer.2017.01.005"},{"key":"2714_CR308","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.2174\/1389450121666200525004714","volume":"21","author":"A Yerlikaya","year":"2020","unstructured":"Yerlikaya, A. & Kanbur, E. The ubiquitin-proteasome pathway and resistance mechanisms developed against the proteasomal inhibitors in cancer cells. Curr. Drug Targets 21, 1313\u20131325 (2020).","journal-title":"Curr. Drug Targets"},{"key":"2714_CR309","doi-asserted-by":"publisher","first-page":"517","DOI":"10.2174\/1568009614666140804154511","volume":"14","author":"QP Dou","year":"2014","unstructured":"Dou, Q. P. & Zonder, J. A. Overview of proteasome inhibitor-based anti-cancer therapies: perspective on bortezomib and second generation proteasome inhibitors versus future generation inhibitors of ubiquitin-proteasome system. Curr. Cancer Drug Targets 14, 517\u2013536 (2014).","journal-title":"Curr. Cancer Drug Targets"},{"key":"2714_CR310","doi-asserted-by":"publisher","first-page":"5772","DOI":"10.1182\/blood-2011-07-366633","volume":"119","author":"N Mimura","year":"2012","unstructured":"Mimura, N. et al. Blockade of XBP1 splicing by inhibition of IRE1\u03b1 is a promising therapeutic option in multiple myeloma. Blood 119, 5772\u20135781 (2012).","journal-title":"Blood"},{"key":"2714_CR311","doi-asserted-by":"publisher","first-page":"16420","DOI":"10.1073\/pnas.1906999116","volume":"116","author":"JM Harnoss","year":"2019","unstructured":"Harnoss, J. M. et al. Disruption of IRE1\u03b1 through its kinase domain attenuates multiple myeloma. Proc. Natl. Acad. Sci. USA 116, 16420\u201316429 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2714_CR312","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1172\/JCI73448","volume":"124","author":"C-HA Tang","year":"2014","unstructured":"Tang, C.-H. A. et al. Inhibition of ER stress-associated IRE-1\/XBP-1 pathway reduces leukemic cell survival. J. Clin. Invest. 124, 2585\u20132598 (2014).","journal-title":"J. Clin. Invest."},{"key":"2714_CR313","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05763-8","volume":"9","author":"SE Logue","year":"2018","unstructured":"Logue, S. E. et al. Inhibition of IRE1 RNase activity modulates the tumor cell secretome and enhances response to chemotherapy. Nat. Commun. 9, 3267 (2018).","journal-title":"Nat. Commun."},{"key":"2714_CR314","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1158\/0008-5472.CAN-12-3109","volume":"73","author":"C Atkins","year":"2013","unstructured":"Atkins, C. et al. Characterization of a novel PERK kinase inhibitor with antitumor and antiangiogenic activity. Cancer Res. 73, 1993\u20132002 (2013).","journal-title":"Cancer Res."},{"key":"2714_CR315","doi-asserted-by":"publisher","first-page":"e1913","DOI":"10.1038\/cddis.2015.264","volume":"6","author":"L Palam","year":"2015","unstructured":"Palam, L. et al. Integrated stress response is critical for gemcitabine resistance in pancreatic ductal adenocarcinoma. Cell Death Dis. 6, e1913\u2013e1913 (2015).","journal-title":"Cell Death Dis."},{"key":"2714_CR316","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1093\/abbs\/gmab131","volume":"53","author":"M Yu","year":"2021","unstructured":"Yu, M. et al. Targeting UPR branches, a potential strategy for enhancing efficacy of cancer chemotherapy. Acta Biochim Biophys. Sin. 53, 1417\u20131427 (2021).","journal-title":"Acta Biochim Biophys. Sin."},{"key":"2714_CR317","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1128\/MCB.01484-13","volume":"34","author":"A Higa","year":"2014","unstructured":"Higa, A. et al. Endoplasmic reticulum stress-activated transcription factor ATF6\u03b1 requires the disulfide isomerase PDIA5 to modulate chemoresistance. Mol. Cell. Biol. 34, 1839\u20131849 (2014).","journal-title":"Mol. Cell. Biol."},{"key":"2714_CR318","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1523\/JNEUROSCI.0151-13.2014","volume":"34","author":"Y Chen","year":"2014","unstructured":"Chen, Y. et al. Hsp90 chaperone inhibitor 17-AAG attenuates Abeta-induced synaptic toxicity and memory impairment. J. Neurosci. 34, 2464\u20132470 (2014).","journal-title":"J. Neurosci."},{"key":"2714_CR319","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3389\/fnins.2017.00254","volume":"11","author":"RE Lackie","year":"2017","unstructured":"Lackie, R. E. et al. The Hsp70\/Hsp90 chaperone machinery in neurodegenerative diseases. Front. Neurosci. 11, 254 (2017).","journal-title":"Front. Neurosci."},{"key":"2714_CR320","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1126\/science.1067389","volume":"295","author":"PK Auluck","year":"2002","unstructured":"Auluck, P. K. et al. Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson\u2019s disease. Science 295, 865\u2013868 (2002).","journal-title":"Science"},{"key":"2714_CR321","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1093\/brain\/aww028","volume":"139","author":"HJ Chen","year":"2016","unstructured":"Chen, H. J. et al. The heat shock response plays an important role in TDP-43 clearance: evidence for dysfunction in amyotrophic lateral sclerosis. Brain 139, 1417\u20131432 (2016).","journal-title":"Brain"},{"key":"2714_CR322","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0022-510X(93)90135-L","volume":"119","author":"H Shinohara","year":"1993","unstructured":"Shinohara, H. et al. Alpha B crystallin and HSP28 are enhanced in the cerebral cortex of patients with Alzheimer\u2019s disease. J. Neurol. Sci. 119, 203\u2013208 (1993).","journal-title":"J. Neurol. Sci."},{"key":"2714_CR323","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00401-005-0030-z","volume":"111","author":"MM Wilhelmus","year":"2006","unstructured":"Wilhelmus, M. M. et al. Small heat shock protein HspB8: its distribution in Alzheimer\u2019s disease brains and its inhibition of amyloid-beta protein aggregation and cerebrovascular amyloid-beta toxicity. Acta Neuropathol. 111, 139\u2013149 (2006).","journal-title":"Acta Neuropathol."},{"key":"2714_CR324","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1002\/jnr.21589","volume":"86","author":"C Bjorkdahl","year":"2008","unstructured":"Bjorkdahl, C. et al. Small heat shock proteins Hsp27 or alphaB-crystallin and the protein components of neurofibrillary tangles: tau and neurofilaments. J. Neurosci. Res. 86, 1343\u20131352 (2008).","journal-title":"J. Neurosci. Res."},{"key":"2714_CR325","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.bbrc.2006.10.085","volume":"351","author":"TF Outeiro","year":"2006","unstructured":"Outeiro, T. F. et al. Small heat shock proteins protect against alpha-synuclein-induced toxicity and aggregation. Biochem. Biophys. Res. Commun. 351, 631\u2013638 (2006).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2714_CR326","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08557-8","volume":"10","author":"TR Alderson","year":"2019","unstructured":"Alderson, T. R. et al. Local unfolding of the HSP27 monomer regulates chaperone activity. Nat. Commun. 10, 1068 (2019).","journal-title":"Nat. Commun."},{"key":"2714_CR327","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1093\/hmg\/11.9.1137","volume":"11","author":"A Wyttenbach","year":"2002","unstructured":"Wyttenbach, A. et al. Heat shock protein 27 prevents cellular polyglutamine toxicity and suppresses the increase of reactive oxygen species caused by huntingtin. Hum. Mol. Genet. 11, 1137\u20131151 (2002).","journal-title":"Hum. Mol. Genet."},{"key":"2714_CR328","doi-asserted-by":"publisher","first-page":"4677","DOI":"10.1093\/hmg\/ddq398","volume":"19","author":"MJ Vos","year":"2010","unstructured":"Vos, M. J. et al. HSPB7 is the most potent polyQ aggregation suppressor within the HSPB family of molecular chaperones. Hum. Mol. Genet. 19, 4677\u20134693 (2010).","journal-title":"Hum. Mol. Genet."},{"key":"2714_CR329","doi-asserted-by":"publisher","first-page":"3908","DOI":"10.1093\/hmg\/ddw232","volume":"25","author":"V Crippa","year":"2016","unstructured":"Crippa, V. et al. The chaperone HSPB8 reduces the accumulation of truncated TDP-43 species in cells and protects against TDP-43-mediated toxicity. Hum. Mol. Genet. 25, 3908\u20133924 (2016).","journal-title":"Hum. Mol. Genet."},{"key":"2714_CR330","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nrn3961","volume":"16","author":"FM Menzies","year":"2015","unstructured":"Menzies, F. M., Fleming, A. & Rubinsztein, D. C. Compromised autophagy and neurodegenerative diseases. Nat. Rev. Neurosci. 16, 345\u2013357 (2015).","journal-title":"Nat. Rev. Neurosci."},{"key":"2714_CR331","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1126\/science.aax3769","volume":"366","author":"C Pohl","year":"2019","unstructured":"Pohl, C. & Dikic, I. Cellular quality control by the ubiquitin-proteasome system and autophagy. Science 366, 818\u2013822 (2019).","journal-title":"Science"},{"key":"2714_CR332","first-page":"1403","volume":"70","author":"I Le Ber","year":"2013","unstructured":"Le Ber, I. et al. SQSTM1 mutations in French patients with frontotemporal dementia or frontotemporal dementia with amyotrophic lateral sclerosis. JAMA Neurol. 70, 1403\u20131410 (2013).","journal-title":"JAMA Neurol."},{"key":"2714_CR333","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","volume":"8","author":"W Zhang","year":"2023","unstructured":"Zhang, W., Xiao, D., Mao, Q. & Xia, H. Role of neuroinflammation in neurodegeneration development. Signal Transduct. Target Ther. 8, 267 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"2714_CR334","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/nm.3232","volume":"19","author":"RA Nixon","year":"2013","unstructured":"Nixon, R. A. The role of autophagy in neurodegenerative disease. Nat. Med. 19, 983\u2013997 (2013).","journal-title":"Nat. Med."},{"key":"2714_CR335","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00401-020-02254-3","volume":"141","author":"JC Polanco","year":"2021","unstructured":"Polanco, J. C. et al. Exosomes induce endolysosomal permeabilization as a gateway by which exosomal tau seeds escape into the cytosol. Acta Neuropathol. 141, 235\u2013256 (2021).","journal-title":"Acta Neuropathol."},{"key":"2714_CR336","doi-asserted-by":"publisher","first-page":"e3001287","DOI":"10.1371\/journal.pbio.3001287","volume":"19","author":"A Dilsizoglu Senol","year":"2021","unstructured":"Dilsizoglu Senol, A. et al. alpha-Synuclein fibrils subvert lysosome structure and function for the propagation of protein misfolding between cells through tunneling nanotubes. PLoS Biol. 19, e3001287 (2021).","journal-title":"PLoS Biol."},{"key":"2714_CR337","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1007\/s12035-020-01926-1","volume":"57","author":"G Monzio Compagnoni","year":"2020","unstructured":"Monzio Compagnoni, G. et al. The role of mitochondria in neurodegenerative diseases: the lesson from Alzheimer\u2019s disease and Parkinson\u2019s disease. Mol. Neurobiol. 57, 2959\u20132980 (2020).","journal-title":"Mol. Neurobiol."},{"key":"2714_CR338","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1093\/brain\/awt196","volume":"136","author":"C Perier","year":"2013","unstructured":"Perier, C. et al. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms. Brain 136, 2369\u20132378 (2013).","journal-title":"Brain"},{"key":"2714_CR339","doi-asserted-by":"publisher","first-page":"e1007947","DOI":"10.1371\/journal.pgen.1007947","volume":"15","author":"P Wang","year":"2019","unstructured":"Wang, P. et al. TDP-43 induces mitochondrial damage and activates the mitochondrial unfolded protein response. PLoS Genet. 15, e1007947 (2019).","journal-title":"PLoS Genet."},{"key":"2714_CR340","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3233\/JAD-2006-9204","volume":"9","author":"SJ Baloyannis","year":"2006","unstructured":"Baloyannis, S. J. Mitochondrial alterations in Alzheimer\u2019s disease. J. Alzheimers Dis. 9, 119\u2013126 (2006).","journal-title":"J. Alzheimers Dis."},{"key":"2714_CR341","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/978-1-0716-2409-8_2","volume":"2515","author":"J Royea","year":"2022","unstructured":"Royea, J. & Khacho, M. Examining mitochondrial morphology in mouse brains. Methods Mol. Biol. 2515, 17\u201328 (2022).","journal-title":"Methods Mol. Biol."},{"key":"2714_CR342","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1007\/s00018-010-0435-2","volume":"67","author":"DH Cho","year":"2010","unstructured":"Cho, D. H., Nakamura, T. & Lipton, S. A. Mitochondrial dynamics in cell death and neurodegeneration. Cell. Mol. Life Sci. 67, 3435\u20133447 (2010).","journal-title":"Cell. Mol. Life Sci."},{"key":"2714_CR343","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.cell.2022.11.001","volume":"186","author":"C Lopez-Otin","year":"2023","unstructured":"Lopez-Otin, C. et al. Hallmarks of aging: an expanding universe. Cell 186, 243\u2013278 (2023).","journal-title":"Cell"},{"key":"2714_CR344","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41593-018-0332-9","volume":"22","author":"EF Fang","year":"2019","unstructured":"Fang, E. F. et al. Mitophagy inhibits amyloid-beta and tau pathology and reverses cognitive deficits in models of Alzheimer\u2019s disease. Nat. Neurosci. 22, 401\u2013412 (2019).","journal-title":"Nat. Neurosci."},{"key":"2714_CR345","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13663","volume":"21","author":"M Vijayan","year":"2022","unstructured":"Vijayan, M. et al. A partial reduction of VDAC1 enhances mitophagy, autophagy, synaptic activities in a transgenic Tau mouse model. Aging Cell 21, e13663 (2022).","journal-title":"Aging Cell"},{"key":"2714_CR346","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1093\/hmg\/ddz004","volume":"28","author":"F Bonello","year":"2019","unstructured":"Bonello, F. et al. LRRK2 impairs PINK1\/Parkin-dependent mitophagy via its kinase activity: pathologic insights into Parkinson\u2019s disease. Hum. Mol. Genet. 28, 1645\u20131660 (2019).","journal-title":"Hum. Mol. Genet."},{"key":"2714_CR347","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1080\/15548627.2019.1603548","volume":"16","author":"F Wauters","year":"2020","unstructured":"Wauters, F. et al. LRRK2 mutations impair depolarization-induced mitophagy through inhibition of mitochondrial accumulation of RAB10. Autophagy 16, 203\u2013222 (2020).","journal-title":"Autophagy"},{"key":"2714_CR348","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.15252\/emmm.201505256","volume":"7","author":"S Hwang","year":"2015","unstructured":"Hwang, S., Disatnik, M. H. & Mochly-Rosen, D. Impaired GAPDH-induced mitophagy contributes to the pathology of Huntington\u2019s disease. EMBO Mol. Med. 7, 1307\u20131326 (2015).","journal-title":"EMBO Mol. Med."},{"key":"2714_CR349","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/nature10353","volume":"477","author":"HX Deng","year":"2011","unstructured":"Deng, H. X. et al. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS\/dementia. Nature 477, 211\u2013215 (2011).","journal-title":"Nature"},{"key":"2714_CR350","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.neuron.2010.11.036","volume":"68","author":"JO Johnson","year":"2010","unstructured":"Johnson, J. O. et al. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron 68, 857\u2013864 (2010).","journal-title":"Neuron"},{"key":"2714_CR351","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/ng1332","volume":"36","author":"GD Watts","year":"2004","unstructured":"Watts, G. D. et al. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat. Genet. 36, 377\u2013381 (2004).","journal-title":"Nat. Genet."},{"key":"2714_CR352","doi-asserted-by":"publisher","first-page":"a009415","DOI":"10.1101\/cshperspect.a009415","volume":"2","author":"MR Cookson","year":"2012","unstructured":"Cookson, M. R. Parkinsonism due to mutations in PINK1, parkin, and DJ-1 and oxidative stress and mitochondrial pathways. Cold Spring Harb. Perspect. Med. 2, a009415 (2012).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"2714_CR353","doi-asserted-by":"publisher","first-page":"101856","DOI":"10.1016\/j.arr.2023.101856","volume":"86","author":"Z Mi","year":"2023","unstructured":"Mi, Z. & Graham, S. H. Role of UCHL1 in the pathogenesis of neurodegenerative diseases and brain injury. Ageing Res. Rev. 86, 101856 (2023).","journal-title":"Ageing Res. Rev."},{"key":"2714_CR354","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.neurobiolaging.2020.11.015","volume":"99","author":"FL Weng","year":"2021","unstructured":"Weng, F. L. & He, L. Disrupted ubiquitin proteasome system underlying tau accumulation in Alzheimer\u2019s disease. Neurobiol. Aging 99, 79\u201385 (2021).","journal-title":"Neurobiol. Aging"},{"key":"2714_CR355","first-page":"1263","volume":"127","author":"EL Scotter","year":"2014","unstructured":"Scotter, E. L. et al. Differential roles of the ubiquitin proteasome system and autophagy in the clearance of soluble and aggregated TDP-43 species. J. Cell Sci. 127, 1263\u20131278 (2014).","journal-title":"J. Cell Sci."},{"key":"2714_CR356","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41392-024-01743-1","volume":"9","author":"JS Loh","year":"2024","unstructured":"Loh, J. S. et al. Microbiota-gut-brain axis and its therapeutic applications in neurodegenerative diseases. Signal Transduct. Target Ther. 9, 37 (2024).","journal-title":"Signal Transduct. Target Ther."},{"key":"2714_CR357","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40478-020-0894-0","volume":"8","author":"C McKinnon","year":"2020","unstructured":"McKinnon, C. et al. Early-onset impairment of the ubiquitin-proteasome system in dopaminergic neurons caused by alpha-synuclein. Acta Neuropathol. Commun. 8, 17 (2020).","journal-title":"Acta Neuropathol. Commun."},{"key":"2714_CR358","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3389\/fnmol.2014.00077","volume":"7","author":"Z Ortega","year":"2014","unstructured":"Ortega, Z. & Lucas, J. J. Ubiquitin-proteasome system involvement in Huntington\u2019s disease. Front. Mol. Neurosci. 7, 77 (2014).","journal-title":"Front. Mol. Neurosci."},{"key":"2714_CR359","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.nbd.2010.08.001","volume":"43","author":"KL Lim","year":"2011","unstructured":"Lim, K. L. & Lim, G. G. K63-linked ubiquitination and neurodegeneration. Neurobiol. Dis. 43, 9\u201316 (2011).","journal-title":"Neurobiol. Dis."},{"key":"2714_CR360","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1042\/BST20211078","volume":"50","author":"F Tokunaga","year":"2022","unstructured":"Tokunaga, F. & Ikeda, F. Linear ubiquitination in immune and neurodegenerative diseases, and beyond. Biochem. Soc. Trans. 50, 799\u2013811 (2022).","journal-title":"Biochem. Soc. Trans."},{"key":"2714_CR361","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202002702R","volume":"35","author":"X Chen","year":"2021","unstructured":"Chen, X. et al. The function of SUMOylation and its crucial roles in the development of neurological diseases. FASEB J. 35, e21510 (2021).","journal-title":"FASEB J."},{"key":"2714_CR362","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.bbrc.2007.01.043","volume":"354","author":"JJ Hoozemans","year":"2007","unstructured":"Hoozemans, J. J. et al. Activation of the unfolded protein response in Parkinson\u2019s disease. Biochem. Biophys. Res. Commun. 354, 707\u2013711 (2007).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2714_CR363","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1002\/jnr.21081","volume":"84","author":"HL Hou","year":"2006","unstructured":"Hou, H. L. et al. Alterations of hHrd1 expression are related to hyperphosphorylated tau in the hippocampus in Alzheimer\u2019s disease. J. Neurosci. Res. 84, 1862\u20131870 (2006).","journal-title":"J. Neurosci. Res."},{"key":"2714_CR364","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/2051-5960-1-31","volume":"1","author":"LD Stutzbach","year":"2013","unstructured":"Stutzbach, L. D. et al. The unfolded protein response is activated in disease-affected brain regions in progressive supranuclear palsy and Alzheimer\u2019s disease. Acta Neuropathol. Commun. 1, 31 (2013).","journal-title":"Acta Neuropathol. Commun."},{"key":"2714_CR365","doi-asserted-by":"publisher","first-page":"18167","DOI":"10.1074\/jbc.M109.018325","volume":"284","author":"A Carnemolla","year":"2009","unstructured":"Carnemolla, A. et al. Rrs1 is involved in endoplasmic reticulum stress response in Huntington disease. J. Biol. Chem. 284, 18167\u201318173 (2009).","journal-title":"J. Biol. Chem."},{"key":"2714_CR366","doi-asserted-by":"publisher","first-page":"5435","DOI":"10.1093\/emboj\/cdg537","volume":"22","author":"C Hetz","year":"2003","unstructured":"Hetz, C. et al. Caspase-12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein. EMBO J. 22, 5435\u20135445 (2003).","journal-title":"EMBO J."},{"key":"2714_CR367","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1101\/gad.1830709","volume":"23","author":"C Hetz","year":"2009","unstructured":"Hetz, C. et al. XBP-1 deficiency in the nervous system protects against amyotrophic lateral sclerosis by increasing autophagy. Genes Dev. 23, 2294\u20132306 (2009).","journal-title":"Genes Dev."},{"key":"2714_CR368","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1097\/NEN.0b013e3181d44992","volume":"69","author":"S Sasaki","year":"2010","unstructured":"Sasaki, S. Endoplasmic reticulum stress in motor neurons of the spinal cord in sporadic amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 69, 346\u2013355 (2010).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"2714_CR369","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1093\/hmg\/dds040","volume":"21","author":"RL Vidal","year":"2012","unstructured":"Vidal, R. L. et al. Targeting the UPR transcription factor XBP1 protects against Huntington\u2019s disease through the regulation of FoxO1 and autophagy. Hum. Mol. Genet. 21, 2245\u20132262 (2012).","journal-title":"Hum. Mol. Genet."},{"key":"2714_CR370","doi-asserted-by":"publisher","DOI":"10.3389\/fragi.2022.846977","volume":"3","author":"I Mossiah","year":"2022","unstructured":"Mossiah, I. et al. Geranylgeranylacetone ameliorates beta-amyloid toxicity and extends lifespan via the heat shock response in Caenorhabditis elegans. Front Aging 3, 846977 (2022).","journal-title":"Front Aging"},{"key":"2714_CR371","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/nature10980","volume":"484","author":"SM Gehrig","year":"2012","unstructured":"Gehrig, S. M. et al. Hsp72 preserves muscle function and slows progression of severe muscular dystrophy. Nature 484, 394\u2013398 (2012).","journal-title":"Nature"},{"key":"2714_CR372","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/2051-5960-1-79","volume":"1","author":"D Ebrahimi-Fakhari","year":"2013","unstructured":"Ebrahimi-Fakhari, D., Saidi, L. J. & Wahlster, L. Molecular chaperones and protein folding as therapeutic targets in Parkinson\u2019s disease and other synucleinopathies. Acta Neuropathol. Commun. 1, 79 (2013).","journal-title":"Acta Neuropathol. Commun."},{"key":"2714_CR373","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.cbpa.2010.03.019","volume":"14","author":"JR Porter","year":"2010","unstructured":"Porter, J. R., Fritz, C. C. & Depew, K. M. Discovery and development of Hsp90 inhibitors: a promising pathway for cancer therapy. Curr. Opin. Chem. Biol. 14, 412\u2013420 (2010).","journal-title":"Curr. Opin. Chem. Biol."},{"key":"2714_CR374","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1124\/jpet.109.158436","volume":"332","author":"P Putcha","year":"2010","unstructured":"Putcha, P. et al. Brain-permeable small-molecule inhibitors of Hsp90 prevent alpha-synuclein oligomer formation and rescue alpha-synuclein-induced toxicity. J. Pharmacol. Exp. Ther. 332, 849\u2013857 (2010).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2714_CR375","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1517\/14728222.2014.943185","volume":"18","author":"LJ Blair","year":"2014","unstructured":"Blair, L. J., Sabbagh, J. J. & Dickey, C. A. Targeting Hsp90 and its co-chaperones to treat Alzheimer\u2019s disease. Expert Opin. Ther. Targets 18, 1219\u20131232 (2014).","journal-title":"Expert Opin. Ther. Targets"},{"key":"2714_CR376","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1080\/15548627.2022.2046437","volume":"18","author":"W Zhang","year":"2022","unstructured":"Zhang, W., Wang, J. & Yang, C. Celastrol, a TFEB (transcription factor EB) agonist, is a promising drug candidate for Alzheimer disease. Autophagy 18, 1740\u20131742 (2022).","journal-title":"Autophagy"},{"key":"2714_CR377","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1021\/acschemneuro.4c00734","volume":"16","author":"I Xavier-de-Britto","year":"2025","unstructured":"Xavier-de-Britto, I. et al. Therapeutic potential of arimoclomol nanomicelles: in vitro impact on Alzheimer\u2019s and Parkinson\u2019s pathology and correlation with in vivo inflammatory response. ACS Chem. Neurosci. 16, 699\u2013710 (2025).","journal-title":"ACS Chem. Neurosci."},{"key":"2714_CR378","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1038\/nrd3453","volume":"10","author":"DW Neef","year":"2011","unstructured":"Neef, D. W., Jaeger, A. M. & Thiele, D. J. Heat shock transcription factor 1 as a therapeutic target in neurodegenerative diseases. Nat. Rev. Drug Discov. 10, 930\u2013944 (2011).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2714_CR379","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/S1474-4422(18)30054-1","volume":"17","author":"T Fang","year":"2018","unstructured":"Fang, T. et al. Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study. Lancet Neurol. 17, 416\u2013422 (2018).","journal-title":"Lancet Neurol."},{"key":"2714_CR380","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/ng1362","volume":"36","author":"B Ravikumar","year":"2004","unstructured":"Ravikumar, B. et al. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat. Genet. 36, 585\u2013595 (2004).","journal-title":"Nat. Genet."},{"key":"2714_CR381","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2025.107294","volume":"132","author":"HM Mubarak","year":"2025","unstructured":"Mubarak, H. M. et al. Exploring the neuroprotective potential of immunosuppressants in Parkinson\u2019s disease. Parkinsonism Relat. Disord. 132, 107294 (2025).","journal-title":"Parkinsonism Relat. Disord."},{"key":"2714_CR382","doi-asserted-by":"publisher","first-page":"21830","DOI":"10.1073\/pnas.0912793107","volume":"107","author":"E Kickstein","year":"2010","unstructured":"Kickstein, E. et al. Biguanide metformin acts on tau phosphorylation via mTOR\/protein phosphatase 2A (PP2A) signaling. Proc. Natl. Acad. Sci. USA 107, 21830\u201321835 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2714_CR383","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2025.110700","volume":"281","author":"Y Kim","year":"2025","unstructured":"Kim, Y. et al. AMPK activation mitigates alpha-synuclein pathology and dopaminergic degeneration in cellular and mouse models of Parkinson\u2019s disease. Neuropharmacology 281, 110700 (2025).","journal-title":"Neuropharmacology"},{"key":"2714_CR384","doi-asserted-by":"publisher","first-page":"5641","DOI":"10.1074\/jbc.M609532200","volume":"282","author":"S Sarkar","year":"2007","unstructured":"Sarkar, S. et al. Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein. J. Biol. Chem. 282, 5641\u20135652 (2007).","journal-title":"J. Biol. Chem."},{"key":"2714_CR385","doi-asserted-by":"crossref","unstructured":"Shabbir, U., Rubab, M., Tyagi, A. & Oh, D. H. Curcumin and its derivatives as theranostic agents in Alzheimer\u2019s disease: the implication of nanotechnology. Int. J. Mol. Sci. 22, 196 (2020).","DOI":"10.3390\/ijms22010196"},{"key":"2714_CR386","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nature11866","volume":"494","author":"S Shoji-Kawata","year":"2013","unstructured":"Shoji-Kawata, S. et al. Identification of a candidate therapeutic autophagy-inducing peptide. Nature 494, 201\u2013206 (2013).","journal-title":"Nature"},{"key":"2714_CR387","doi-asserted-by":"publisher","first-page":"3462","DOI":"10.1021\/acsptsci.4c00283","volume":"7","author":"E Mishra","year":"2024","unstructured":"Mishra, E. & Thakur, M. K. Tat-Beclin-1 ameliorates memory by improving neuronal cytoarchitecture and mitigating mitochondrial dysfunction in scopolamine-induced amnesic male mice. ACS Pharm. Transl. Sci. 7, 3462\u20133475 (2024).","journal-title":"ACS Pharm. Transl. Sci."},{"key":"2714_CR388","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1083\/jcb.200504035","volume":"170","author":"S Sarkar","year":"2005","unstructured":"Sarkar, S. et al. Lithium induces autophagy by inhibiting inositol monophosphatase. J. Cell Biol. 170, 1101\u20131111 (2005).","journal-title":"J. Cell Biol."},{"key":"2714_CR389","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1080\/15548627.2022.2116832","volume":"19","author":"L Wrobel","year":"2023","unstructured":"Wrobel, L., Hill, S. M. & Rubinsztein, D. C. SMER28 binding to VCP\/p97 enhances both autophagic and proteasomal neurotoxic protein clearance. Autophagy 19, 1348\u20131350 (2023).","journal-title":"Autophagy"},{"key":"2714_CR390","doi-asserted-by":"publisher","first-page":"9100","DOI":"10.1074\/jbc.M109.060061","volume":"285","author":"V Vingtdeux","year":"2010","unstructured":"Vingtdeux, V. et al. AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism. J. Biol. Chem. 285, 9100\u20139113 (2010).","journal-title":"J. Biol. Chem."},{"key":"2714_CR391","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.161","volume":"8","author":"Y Yang","year":"2017","unstructured":"Yang, Y. et al. Induction of autophagy by spermidine is neuroprotective via inhibition of caspase 3-mediated Beclin 1 cleavage. Cell Death Dis. 8, e2738 (2017).","journal-title":"Cell Death Dis."},{"key":"2714_CR392","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1093\/hmg\/ddw095","volume":"25","author":"A Chandra","year":"2016","unstructured":"Chandra, A. et al. Enhanced mitochondrial biogenesis ameliorates disease phenotype in a full-length mouse model of Huntington\u2019s disease. Hum. Mol. Genet. 25, 2269\u20132282 (2016).","journal-title":"Hum. Mol. Genet."},{"key":"2714_CR393","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1002\/mds.23148","volume":"25","author":"BJ Snow","year":"2010","unstructured":"Snow, B. J. et al. A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson\u2019s disease. Mov. Disord. 25, 1670\u20131674 (2010).","journal-title":"Mov. Disord."},{"key":"2714_CR394","doi-asserted-by":"publisher","first-page":"4212","DOI":"10.1002\/alz.13847","volume":"20","author":"Y Hou","year":"2024","unstructured":"Hou, Y. et al. Urolithin A improves Alzheimer\u2019s disease cognition and restores mitophagy and lysosomal functions. Alzheimers Dement 20, 4212\u20134233 (2024).","journal-title":"Alzheimers Dement"},{"key":"2714_CR395","doi-asserted-by":"crossref","unstructured":"Hertz, N. et al. Pharmacological PINK1 activation ameliorates pathology in Parkinson\u2019s Disease models. Res. Sq., rs.3.rs-4356493 (2024).","DOI":"10.21203\/rs.3.rs-4356493\/v1"},{"key":"2714_CR396","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.cell.2013.07.030","volume":"154","author":"NT Hertz","year":"2013","unstructured":"Hertz, N. T. et al. A neo-substrate that amplifies catalytic activity of parkinson\u2019s-disease-related kinase PINK1. Cell 154, 737\u2013747 (2013).","journal-title":"Cell"},{"key":"2714_CR397","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.devcel.2017.02.020","volume":"40","author":"EA Bordt","year":"2017","unstructured":"Bordt, E. A. et al. The putative Drp1 inhibitor mdivi-1 is a reversible mitochondrial complex I inhibitor that modulates reactive oxygen species. Dev. Cell. 40, 583\u2013594.e586 (2017).","journal-title":"Dev. Cell."},{"key":"2714_CR398","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.bcp.2018.01.038","volume":"150","author":"A Szabo","year":"2018","unstructured":"Szabo, A. et al. Activation of mitochondrial fusion provides a new treatment for mitochondria-related diseases. Biochem. Pharmacol. 150, 86\u201396 (2018).","journal-title":"Biochem. Pharmacol."},{"key":"2714_CR399","doi-asserted-by":"publisher","first-page":"5035","DOI":"10.1073\/pnas.1620212114","volume":"114","author":"SB Ohlen","year":"2017","unstructured":"Ohlen, S. B., Russell, M. L., Brownstein, M. J. & Lefcort, F. BGP-15 prevents the death of neurons in a mouse model of familial dysautonomia. Proc. Natl. Acad. Sci. USA 114, 5035\u20135040 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2714_CR400","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.brainres.2017.03.018","volume":"1663","author":"Y Lee","year":"2017","unstructured":"Lee, Y. et al. Neuroprotective effects of 2,4-dinitrophenol in an acute model of Parkinson\u2019s disease. Brain Res. 1663, 184\u2013193 (2017).","journal-title":"Brain Res."},{"key":"2714_CR401","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.expneurol.2017.03.020","volume":"293","author":"B Wu","year":"2017","unstructured":"Wu, B. et al. 2,4 DNP improves motor function, preserves medium spiny neuronal identity, and reduces oxidative stress in a mouse model of Huntington\u2019s disease. Exp. Neurol. 293, 83\u201390 (2017).","journal-title":"Exp. Neurol."},{"key":"2714_CR402","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nm.4011","volume":"22","author":"N Myeku","year":"2016","unstructured":"Myeku, N. et al. Tau-driven 26S proteasome impairment and cognitive dysfunction can be prevented early in disease by activating cAMP-PKA signaling. Nat. Med. 22, 46\u201353 (2016).","journal-title":"Nat. Med."},{"key":"2714_CR403","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1126\/science.1245321","volume":"342","author":"DF Tardiff","year":"2013","unstructured":"Tardiff, D. F. et al. Yeast reveal a \u201cdruggable\u201d Rsp5\/Nedd4 network that ameliorates alpha-synuclein toxicity in neurons. Science 342, 979\u2013983 (2013).","journal-title":"Science"},{"key":"2714_CR404","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2025.117324","volume":"287","author":"P Liu","year":"2025","unstructured":"Liu, P. et al. Recent advances in small molecule inhibitors of deubiquitinating enzymes. Eur. J. Med. Chem. 287, 117324 (2025).","journal-title":"Eur. J. Med. Chem."},{"key":"2714_CR405","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.3233\/JAD-140066","volume":"41","author":"L Zhang","year":"2014","unstructured":"Zhang, L. et al. Tubastatin A\/ACY-1215 improves cognition in Alzheimer\u2019s disease transgenic mice. J. Alzheimers Dis. 41, 1193\u20131205 (2014).","journal-title":"J. Alzheimers Dis."},{"key":"2714_CR406","doi-asserted-by":"publisher","first-page":"65","DOI":"10.4062\/biomolther.2023.134","volume":"32","author":"SY Sohn","year":"2024","unstructured":"Sohn, S. Y., San, T. T., Kim, J. & Kim, H. J. Bortezomib is toxic but induces neurogenesis and inhibits TUBB3 degradation in rat neural stem cells. Biomol. Ther. 32, 65\u201376 (2024).","journal-title":"Biomol. Ther."},{"key":"2714_CR407","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1111\/febs.15536","volume":"288","author":"N LeBlanc","year":"2021","unstructured":"LeBlanc, N., Mallette, E. & Zhang, W. Targeted modulation of E3 ligases using engineered ubiquitin variants. FEBS J. 288, 2143\u20132165 (2021).","journal-title":"FEBS J."},{"key":"2714_CR408","doi-asserted-by":"publisher","DOI":"10.1126\/science.add6696","volume":"381","author":"ZY Zhang","year":"2023","unstructured":"Zhang, Z. Y. et al. TRIM11 protects against tauopathies and is down-regulated in Alzheimer\u2019s disease. Science 381, eadd6696 (2023).","journal-title":"Science"},{"key":"2714_CR409","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41392-023-01729-5","volume":"9","author":"Y Fu","year":"2024","unstructured":"Fu, Y., Zhang, B. & Liu, J. Tripartite motif-containing protein 11 (TRIM11): a novel weapon against Alzheimer\u2019s disease. Signal Transduct. Target Ther. 9, 3 (2024).","journal-title":"Signal Transduct. Target Ther."},{"key":"2714_CR410","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/s41392-024-02004-x","volume":"9","author":"G Zhong","year":"2024","unstructured":"Zhong, G., Chang, X., Xie, W. & Zhou, X. Targeted protein degradation: advances in drug discovery and clinical practice. Signal Transduct. Target Ther. 9, 308 (2024).","journal-title":"Signal Transduct. Target Ther."},{"key":"2714_CR411","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s41392-019-0101-6","volume":"4","author":"X Sun","year":"2019","unstructured":"Sun, X. et al. PROTACs: great opportunities for academia and industry. Signal Transduct. Target Ther. 4, 64 (2019).","journal-title":"Signal Transduct. Target Ther."},{"key":"2714_CR412","doi-asserted-by":"crossref","unstructured":"Maity, S. et al. Impact of ER stress and ER-mitochondrial crosstalk in Huntington\u2019s disease. Int. J. Mol. Sci. 23, 780 (2022).","DOI":"10.3390\/ijms23020780"},{"key":"2714_CR413","doi-asserted-by":"crossref","unstructured":"Plate, L. et al. Small molecule proteostasis regulators that reprogram the ER to reduce extracellular protein aggregation. Elife. 5, e15550 (2016).","DOI":"10.7554\/eLife.15550"},{"key":"2714_CR414","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.cell.2014.07.002","volume":"158","author":"R Ghosh","year":"2014","unstructured":"Ghosh, R. et al. Allosteric inhibition of the IRE1alpha RNase preserves cell viability and function during endoplasmic reticulum stress. Cell 158, 534\u2013548 (2014).","journal-title":"Cell"},{"key":"2714_CR415","doi-asserted-by":"publisher","first-page":"15692","DOI":"10.1074\/jbc.REV120.010218","volume":"295","author":"JMD Grandjean","year":"2020","unstructured":"Grandjean, J. M. D. & Wiseman, R. L. Small molecule strategies to harness the unfolded protein response: where do we go from here? J. Biol. Chem. 295, 15692\u201315711 (2020).","journal-title":"J. Biol. Chem."},{"key":"2714_CR416","doi-asserted-by":"publisher","first-page":"206ra138","DOI":"10.1126\/scitranslmed.3006767","volume":"5","author":"JA Moreno","year":"2013","unstructured":"Moreno, J. A. et al. Oral treatment targeting the unfolded protein response prevents neurodegeneration and clinical disease in prion-infected mice. Sci. Transl. Med. 5, 206ra138 (2013).","journal-title":"Sci. Transl. Med."},{"key":"2714_CR417","doi-asserted-by":"crossref","unstructured":"Oliveira, M. M. et al. Correction of eIF2-dependent defects in brain protein synthesis, synaptic plasticity, and memory in mouse models of Alzheimer\u2019s disease. Sci. Signal. 14, eabc5429 (2021).","DOI":"10.1126\/scisignal.abc5429"},{"key":"2714_CR418","doi-asserted-by":"publisher","first-page":"10671","DOI":"10.1073\/pnas.162362299","volume":"99","author":"CD Keene","year":"2002","unstructured":"Keene, C. D. et al. Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic animal model of Huntington\u2019s disease. Proc. Natl. Acad. Sci. USA 99, 10671\u201310676 (2002).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2714_CR419","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1111\/j.1471-4159.2006.04440.x","volume":"101","author":"M Inden","year":"2007","unstructured":"Inden, M. et al. Neurodegeneration of mouse nigrostriatal dopaminergic system induced by repeated oral administration of rotenone is prevented by 4-phenylbutyrate, a chemical chaperone. J. Neurochem. 101, 1491\u20131504 (2007).","journal-title":"J. Neurochem."},{"key":"2714_CR420","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1038\/npp.2008.229","volume":"34","author":"A Ricobaraza","year":"2009","unstructured":"Ricobaraza, A. et al. Phenylbutyrate ameliorates cognitive deficit and reduces tau pathology in an Alzheimer\u2019s disease mouse model. Neuropsychopharmacology 34, 1721\u20131732 (2009).","journal-title":"Neuropsychopharmacology"},{"key":"2714_CR421","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/icb.1992.37","volume":"70","author":"J Panchapakesan","year":"1992","unstructured":"Panchapakesan, J., Daglis, M. & Gatenby, P. Antibodies to 65 kDa and 70 kDa heat shock proteins in rheumatoid arthritis and systemic lupus erythematosus. Immunol. Cell Biol. 70, 295\u2013300 (1992).","journal-title":"Immunol. Cell Biol."},{"key":"2714_CR422","doi-asserted-by":"crossref","unstructured":"Stephanou, A., Latchman, D. S. & Isenberg, D. A. The regulation of heat shock proteins and their role in systemic lupus erythematosus. Semin. Arthritis Rheum. 28 155\u2013162 (1998).","DOI":"10.1016\/S0049-0172(98)80032-2"},{"key":"2714_CR423","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1002\/art.20564","volume":"50","author":"M Dieud\u00e9","year":"2004","unstructured":"Dieud\u00e9, M., Sen\u00e9cal, J. L. & Raymond, Y. Induction of endothelial cell apoptosis by heat-shock protein 60-reactive antibodies from anti-endothelial cell autoantibody-positive systemic lupus erythematosus patients. Arthritis Rheum. 50, 3221\u20133231 (2004).","journal-title":"Arthritis Rheum."},{"key":"2714_CR424","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3109\/03009742.2011.552522","volume":"40","author":"L Sedlackova","year":"2011","unstructured":"Sedlackova, L. et al. Heat shock protein gene expression profile may differentiate between rheumatoid arthritis, osteoarthritis, and healthy controls. Scand. J. Rheumatol. 40, 354\u2013357 (2011).","journal-title":"Scand. J. Rheumatol."},{"key":"2714_CR425","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1421528","volume":"15","author":"S Tukaj","year":"2024","unstructured":"Tukaj, S. Dual role of autoantibodies to heat shock proteins in autoimmune diseases. Front. Immunol. 15, 1421528 (2024).","journal-title":"Front. Immunol."},{"key":"2714_CR426","doi-asserted-by":"publisher","first-page":"327","DOI":"10.18388\/abp.2010_2412","volume":"57","author":"S Tukaj","year":"2010","unstructured":"Tukaj, S. et al. Cytokines of the Th1 and Th2 type in sera of rheumatoid arthritis patients; correlations with anti-Hsp40 immune response and diagnostic markers. Acta Biochim. Pol. 57, 327\u2013332 (2010).","journal-title":"Acta Biochim. Pol."},{"key":"2714_CR427","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s12192-018-0951-9","volume":"24","author":"J Mantej","year":"2019","unstructured":"Mantej, J., Polasik, K., Piotrowska, E. & Tukaj, S. Autoantibodies to heat shock proteins 60, 70, and 90 in patients with rheumatoid arthritis. Cell Stress Chaperones 24, 283\u2013287 (2019).","journal-title":"Cell Stress Chaperones"},{"key":"2714_CR428","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/00005072-199604000-00001","volume":"55","author":"CF Brosnan","year":"1996","unstructured":"Brosnan, C. F. et al. Heat shock proteins and multiple sclerosis: a review. J. Neuropathol. Exp. Neurol. 55, 389\u2013402 (1996).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"2714_CR429","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1097\/NEN.0000000000000136","volume":"73","author":"G Turturici","year":"2014","unstructured":"Turturici, G. et al. Positive or negative involvement of heat shock proteins in multiple sclerosis pathogenesis: An overview. J. Neuropathol. Exp. Neurol. 73, 1092\u20131106 (2014).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"2714_CR430","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/978-1-4615-0123-7_10","volume":"513","author":"MA Yenari","year":"2002","unstructured":"Yenari, M. A. Heat shock proteins and neuroprotection. Adv. Exp. Med. Biol. 513, 281\u2013299 (2002).","journal-title":"Adv. Exp. Med. Biol."},{"key":"2714_CR431","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/nrn1477","volume":"5","author":"SC Benn","year":"2004","unstructured":"Benn, S. C. & Woolf, C. J. Adult neuron survival strategies\u2014slamming on the brakes. Nat. Rev. Neurosci. 5, 686\u2013700 (2004).","journal-title":"Nat. Rev. Neurosci."},{"key":"2714_CR432","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/02656730500088211","volume":"21","author":"M Fleshner","year":"2005","unstructured":"Fleshner, M. & Johnson, J. Endogenous extra-cellular heat shock protein 72: releasing signal(s) and function. Int. J. Hyperth. 21, 457\u2013471 (2005).","journal-title":"Int. J. Hyperth."},{"key":"2714_CR433","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jns.2005.10.009","volume":"241","author":"S Chiba","year":"2006","unstructured":"Chiba, S. et al. Autoantibodies against HSP70 family proteins were detected in the cerebrospinal fluid from patients with multiple sclerosis. J. Neurol. Sci. 241, 39\u201343 (2006).","journal-title":"J. Neurol. Sci."},{"key":"2714_CR434","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1191\/135248506ms1271oa","volume":"12","author":"J Van Noort","year":"2006","unstructured":"Van Noort, J. et al. Autoantibodies against alpha B-crystallin, a candidate autoantigen in multiple sclerosis, are part of a normal human immune repertoire. Mult. Scler. 12, 287\u2013293 (2006).","journal-title":"Mult. Scler."},{"key":"2714_CR435","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/nature05935","volume":"448","author":"SS Ousman","year":"2007","unstructured":"Ousman, S. S. et al. Protective and therapeutic role for \u03b1B-crystallin in autoimmune demyelination. Nature 448, 474\u2013479 (2007).","journal-title":"Nature"},{"key":"2714_CR436","doi-asserted-by":"publisher","first-page":"4508","DOI":"10.3390\/ijms20184508","volume":"20","author":"P Martine","year":"2019","unstructured":"Martine, P. & R\u00e9b\u00e9, C. Heat shock proteins and inflammasomes. Int. J. Mol. Sci. 20, 4508 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"2714_CR437","doi-asserted-by":"publisher","first-page":"920","DOI":"10.3389\/fphar.2019.00920","volume":"10","author":"B Dukay","year":"2019","unstructured":"Dukay, B., Csoboz, B. & T\u00f3th, M. E. Heat-shock proteins in neuroinflammation. Front. Pharmacol. 10, 920 (2019).","journal-title":"Front. Pharmacol."},{"key":"2714_CR438","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.cstres.2024.01.002","volume":"29","author":"HT Schroeder","year":"2024","unstructured":"Schroeder, H. T. et al. Heat shock response during the resolution of inflammation and its progressive suppression in chronic-degenerative inflammatory diseases. Cell Stress Chaperones 29, 116\u2013142 (2024).","journal-title":"Cell Stress Chaperones"},{"key":"2714_CR439","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jaut.2006.06.006","volume":"27","author":"D Zlacka","year":"2006","unstructured":"Zlacka, D., Vavrincova, P., Nguyen, T. T. H. & Hromadnikova, I. Frequency of anti-hsp60,-65 and-70 antibodies in sera of patients with juvenile idiopathic arthritis. J. Autoimmun. 27, 81\u201388 (2006).","journal-title":"J. Autoimmun."},{"key":"2714_CR440","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00005-020-00573-7","volume":"68","author":"A Damasiewicz-Bodzek","year":"2020","unstructured":"Damasiewicz-Bodzek, A., Szumska, M. & Tyrpie\u0144-Golder, K. Antibodies to heat shock proteins 90\u03b1 and 90\u03b2 in psoriasis. Arch. Immunol. Ther. Exp. 68, 9 (2020).","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"2714_CR441","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/096120339100100102","volume":"1","author":"V Dhillon","year":"1991","unstructured":"Dhillon, V., Latchman, D. & Isenberg, D. Heat shock proteins and systemic lupus erythematosus. Lupus 1, 3\u20138 (1991).","journal-title":"Lupus"},{"key":"2714_CR442","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s12192-021-01238-w","volume":"26","author":"K Sitko","year":"2021","unstructured":"Sitko, K. et al. Circulating heat shock protein 90 (Hsp90) and autoantibodies to Hsp90 are increased in patients with atopic dermatitis. Cell Stress Chaperones 26, 1001\u20131007 (2021).","journal-title":"Cell Stress Chaperones"},{"key":"2714_CR443","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jsbmb.2016.10.002","volume":"173","author":"S Tukaj","year":"2017","unstructured":"Tukaj, S. et al. Autoimmunity to heat shock proteins and vitamin D status in patients with celiac disease without associated dermatitis herpetiformis. J. Steroid Biochem. Mol. Biol. 173, 23\u201327 (2017).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"2714_CR444","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3109\/08820139809022710","volume":"27","author":"A Pockley","year":"1998","unstructured":"Pockley, A., Shepherd, J. & Corton, J. Detection of heat shock protein 70 (Hsp70) and anti-Hsp70 antibodies in the serum of normal individuals. Immunol. Invest. 27, 367\u2013377 (1998).","journal-title":"Immunol. Invest."},{"key":"2714_CR445","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/ijd.16487","volume":"62","author":"LA Ochoa-Ramirez","year":"2023","unstructured":"Ochoa-Ramirez, L. A. et al. Analysis of the heat shock protein 70 (HSP70) genetic variants in nonsegmental vitiligo patients. Int. J. Dermatol. 62, 225\u2013230 (2023).","journal-title":"Int. J. Dermatol."},{"key":"2714_CR446","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.3390\/biom12081153","volume":"12","author":"S Tukaj","year":"2022","unstructured":"Tukaj, S. & Sitko, K. Heat shock protein 90 (Hsp90) and Hsp70 as potential therapeutic targets in autoimmune skin diseases. Biomolecules 12, 1153 (2022).","journal-title":"Biomolecules"},{"key":"2714_CR447","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1002\/art.20999","volume":"52","author":"D Alarc\u00f3n-Segovia","year":"2005","unstructured":"Alarc\u00f3n-Segovia, D. et al. Grupo Latinoamericano de Estudio del Lupus Eritematoso (GLADEL). Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort. Arthritis Rheum. 52, 1138\u20131147 (2005).","journal-title":"Arthritis Rheum."},{"key":"2714_CR448","first-page":"1205","volume":"26","author":"JE Molineros","year":"2017","unstructured":"Molineros, J. E. et al. Confirmation of five novel susceptibility loci for systemic lupus erythematosus (SLE) and integrated network analysis of 82 SLE susceptibility loci. Hum. Mol. Genet. 26, 1205\u20131216 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"2714_CR449","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1136\/ard.2010.140111","volume":"70","author":"XJ Zhou","year":"2011","unstructured":"Zhou, X. J. et al. Genetic association of PRDM1-ATG5 intergenic region and autophagy with systemic lupus erythematosus in a Chinese population. Ann. Rheum. Dis. 70, 1330\u20131337 (2011).","journal-title":"Ann. Rheum. Dis."},{"key":"2714_CR450","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.1002\/art.39296","volume":"67","author":"H Wang","year":"2015","unstructured":"Wang, H. et al. Neutrophil extracellular trap mitochondrial DNA and its autoantibody in systemic lupus erythematosus and a proof-of-concept trial of metformin. Arthritis Rheumatol. 67, 3190\u20133200 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"2714_CR451","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/nature07383","volume":"456","author":"T Saitoh","year":"2008","unstructured":"Saitoh, T. et al. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1\u03b2 production. Nature 456, 264\u2013268 (2008).","journal-title":"Nature"},{"key":"2714_CR452","first-page":"705","volume":"32","author":"B Li","year":"2014","unstructured":"Li, B. et al. Blockade of macrophage autophagy ameliorates activated lymphocytes-derived DNA induced murine lupus possibly via inhibition of proinflammatory cytokine production. Clin. Exp. Rheumatol. 32, 705\u2013714 (2014).","journal-title":"Clin. Exp. Rheumatol."},{"key":"2714_CR453","first-page":"403","volume":"55","author":"Y Dai","year":"2016","unstructured":"Dai, Y. & Hu, S. Recent insights into the role of autophagy in the pathogenesis of rheumatoid arthritis. Rheumatology 55, 403\u2013410 (2016).","journal-title":"Rheumatology"},{"key":"2714_CR454","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1136\/annrheumdis-2012-201671","volume":"72","author":"NY Lin","year":"2013","unstructured":"Lin, N. Y. et al. Autophagy regulates TNFalpha-mediated joint destruction in experimental arthritis. Ann. Rheum. Dis. 72, 761\u2013768 (2013).","journal-title":"Ann. Rheum. Dis."},{"key":"2714_CR455","first-page":"2179","volume":"40","author":"J-T Ding","year":"2022","unstructured":"Ding, J.-T., Hong, F.-F. & Yang, S.-L. Roles of autophagy in rheumatoid arthritis. Clin. Exp. Rheumatol. 40, 2179\u20132187 (2022).","journal-title":"Clin. Exp. Rheumatol."},{"key":"2714_CR456","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10753-020-01324-8","volume":"44","author":"S Chadha","year":"2021","unstructured":"Chadha, S. et al. Focus on the multimodal role of autophagy in rheumatoid arthritis. Inflammation 44, 1\u201312 (2021).","journal-title":"Inflammation"},{"key":"2714_CR457","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/7623145","volume":"2017","author":"L Zhu","year":"2017","unstructured":"Zhu, L. et al. The autophagy level is increased in the synovial tissues of patients with active rheumatoid arthritis and is correlated with disease severity. Mediators Inflamm. 2017, 7623145 (2017).","journal-title":"Mediators Inflamm."},{"key":"2714_CR458","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar3778","volume":"14","author":"AM Connor","year":"2012","unstructured":"Connor, A. M. et al. TNF\u03b1 modulates protein degradation pathways in rheumatoid arthritis synovial fibroblasts. Arthritis Res. Ther. 14, 1\u201319 (2012).","journal-title":"Arthritis Res. Ther."},{"key":"2714_CR459","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1080\/15548627.2023.2259281","volume":"20","author":"HM Al-Kuraishy","year":"2024","unstructured":"Al-Kuraishy, H. M. et al. The beneficial role of autophagy in multiple sclerosis: yes or no? Autophagy 20, 259\u2013274 (2024).","journal-title":"Autophagy"},{"key":"2714_CR460","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.gene.2016.04.042","volume":"588","author":"M Igci","year":"2016","unstructured":"Igci, M. et al. Gene expression profiles of autophagy-related genes in multiple sclerosis. Gene 588, 38\u201346 (2016).","journal-title":"Gene"},{"key":"2714_CR461","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2019.577067","volume":"337","author":"Y Boyao","year":"2019","unstructured":"Boyao, Y. et al. Dynamic expression of autophagy-related factors in autoimmune encephalomyelitis and exploration of curcumin therapy. J. Neuroimmunol. 337, 577067 (2019).","journal-title":"J. Neuroimmunol."},{"key":"2714_CR462","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1016\/j.celrep.2016.05.009","volume":"15","author":"IY Choi","year":"2016","unstructured":"Choi, I. Y. et al. A diet mimicking fasting promotes regeneration and reduces autoimmunity and multiple sclerosis symptoms. Cell Rep. 15, 2136\u20132146 (2016).","journal-title":"Cell Rep."},{"key":"2714_CR463","doi-asserted-by":"publisher","DOI":"10.20900\/immunometab20200017","volume":"2","author":"B Wu","year":"2020","unstructured":"Wu, B., Goronzy, J. J. & Weyand, C. M. Metabolic fitness of T cells in autoimmune disease. Immunometabolism 2, e200017 (2020).","journal-title":"Immunometabolism"},{"key":"2714_CR464","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.celrep.2018.09.001","volume":"25","author":"K Gkirtzimanaki","year":"2018","unstructured":"Gkirtzimanaki, K. et al. IFNalpha impairs autophagic degradation of mtDNA promoting autoreactivity of SLE monocytes in a STING-dependent fashion. Cell Rep. 25, 921\u2013933.e925 (2018).","journal-title":"Cell Rep."},{"key":"2714_CR465","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.humimm.2014.06.012","volume":"75","author":"L Chen","year":"2014","unstructured":"Chen, L. et al. Experimental evidence that mutated-self peptides derived from mitochondrial DNA somatic mutations have the potential to trigger autoimmunity. Hum. Immunol. 75, 873\u2013879 (2014).","journal-title":"Hum. Immunol."},{"key":"2714_CR466","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cellimm.2007.06.007","volume":"247","author":"K Alam","year":"2007","unstructured":"Alam, K. & Jabeen, S. Immunogenicity of mitochondrial DNA modified by hydroxyl radical. Cell. Immunol. 247, 12\u201317 (2007).","journal-title":"Cell. Immunol."},{"key":"2714_CR467","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.clim.2008.07.011","volume":"129","author":"T Vyshkina","year":"2008","unstructured":"Vyshkina, T. et al. Association of common mitochondrial DNA variants with multiple sclerosis and systemic lupus erythematosus. Clin. Immunol. 129, 31\u201335 (2008).","journal-title":"Clin. Immunol."},{"key":"2714_CR468","doi-asserted-by":"publisher","first-page":"375","DOI":"10.46497\/ArchRheumatol.2021.8101","volume":"36","author":"R Lai","year":"2021","unstructured":"Lai, R. et al. Identification of sequence polymorphisms in the mitochondrial deoxyribonucleic acid displacement-loop region as risk factors for systemic lupus erythematosus. Arch. Rheumatol. 36, 375 (2021).","journal-title":"Arch. Rheumatol."},{"key":"2714_CR469","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.cmet.2019.06.016","volume":"30","author":"Y Li","year":"2019","unstructured":"Li, Y. et al. The DNA repair nuclease MRE11A functions as a mitochondrial protector and prevents T cell pyroptosis and tissue inflammation. Cell Metab. 30, 477\u2013492.e476 (2019).","journal-title":"Cell Metab."},{"key":"2714_CR470","doi-asserted-by":"publisher","first-page":"673916","DOI":"10.3389\/fimmu.2021.673916","volume":"12","author":"SA Clayton","year":"2021","unstructured":"Clayton, S. A., MacDonald, L., Kurowska-Stolarska, M. & Clark, A. R. Mitochondria as key players in the pathogenesis and treatment of rheumatoid arthritis. Front. Immunol. 12, 673916 (2021).","journal-title":"Front. Immunol."},{"key":"2714_CR471","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.1182\/blood-2016-02-697003","volume":"128","author":"I Duroux-Richard","year":"2016","unstructured":"Duroux-Richard, I. et al. miR-125b controls monocyte adaptation to inflammation through mitochondrial metabolism and dynamics. Blood 128, 3125\u20133136 (2016).","journal-title":"Blood"},{"key":"2714_CR472","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/path.4159","volume":"229","author":"KJ Morten","year":"2013","unstructured":"Morten, K. J., Badder, L. & Knowles, H. J. Differential regulation of HIF-mediated pathways increases mitochondrial metabolism and ATP production in hypoxic osteoclasts. J. Pathol. 229, 755\u2013764 (2013).","journal-title":"J. Pathol."},{"key":"2714_CR473","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar787","volume":"5","author":"S Hajizadeh","year":"2003","unstructured":"Hajizadeh, S. et al. Extracellular mitochondrial DNA and oxidatively damaged DNA in synovial fluid of patients with rheumatoid arthritis. Arthritis Res. Ther. 5, 1\u20137 (2003).","journal-title":"Arthritis Res. Ther."},{"key":"2714_CR474","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar1752","volume":"7","author":"TR Da Sylva","year":"2005","unstructured":"Da Sylva, T. R. et al. Somatic mutations in the mitochondria of rheumatoid arthritis synoviocytes. Arthritis Res. Ther. 7, 1\u20138 (2005).","journal-title":"Arthritis Res. Ther."},{"key":"2714_CR475","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1136\/annrheumdis-2011-200245","volume":"71","author":"LC Harty","year":"2012","unstructured":"Harty, L. C. et al. Mitochondrial mutagenesis correlates with the local inflammatory environment in arthritis. Ann. Rheum. Dis. 71, 582\u2013588 (2012).","journal-title":"Ann. Rheum. Dis."},{"key":"2714_CR476","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3390\/biology8020037","volume":"8","author":"IPD Barcelos","year":"2019","unstructured":"Barcelos, I. P. D., Troxell, R. M. & Graves, J. S. Mitochondrial dysfunction and multiple sclerosis. Biology 8, 37 (2019).","journal-title":"Biology"},{"key":"2714_CR477","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.mito.2009.12.141","volume":"10","author":"R Schoenfeld","year":"2010","unstructured":"Schoenfeld, R. et al. Oligodendroglial differentiation induces mitochondrial genes and inhibition of mitochondrial function represses oligodendroglial differentiation. Mitochondrion 10, 143\u2013150 (2010).","journal-title":"Mitochondrion"},{"key":"2714_CR478","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/ana.22109","volume":"69","author":"GR Campbell","year":"2011","unstructured":"Campbell, G. R. et al. Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis. Ann. Neurol. 69, 481\u2013492 (2011).","journal-title":"Ann. Neurol."},{"key":"2714_CR479","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1007\/s11064-013-1151-8","volume":"38","author":"S Li","year":"2013","unstructured":"Li, S. et al. Decreased NAA in gray matter is correlated with decreased availability of acetate in white matter in postmortem multiple sclerosis cortex. Neurochem. Res. 38, 2385\u20132396 (2013).","journal-title":"Neurochem. Res."},{"key":"2714_CR480","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3390\/biomedicines8040085","volume":"8","author":"D De Rasmo","year":"2020","unstructured":"De Rasmo, D. et al. PBMC of multiple sclerosis patients show deregulation of OPA1 processing associated with increased ROS and PHB2 protein levels. Biomedicines 8, 85 (2020).","journal-title":"Biomedicines"},{"key":"2714_CR481","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00415-005-0965-y","volume":"253","author":"M Ruggieri","year":"2006","unstructured":"Ruggieri, M. et al. Glatiramer acetate induces pro\u2013apoptotic mechanisms involving Bcl\u20132, Bax and Cyt\u2013c in peripheral lymphocytes from multiple sclerosis patients. J. Neurol. 253, 231\u2013236 (2006).","journal-title":"J. Neurol."},{"key":"2714_CR482","doi-asserted-by":"publisher","first-page":"938","DOI":"10.3389\/fnins.2019.00938","volume":"13","author":"H Gonzalo","year":"2019","unstructured":"Gonzalo, H. et al. Impairment of mitochondrial redox status in peripheral lymphocytes of multiple sclerosis patients. Front. Neurosci. 13, 938 (2019).","journal-title":"Front. Neurosci."},{"key":"2714_CR483","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.metabol.2017.08.011","volume":"77","author":"C La Rocca","year":"2017","unstructured":"La Rocca, C. et al. Immunometabolic profiling of T cells from patients with relapsing-remitting multiple sclerosis reveals an impairment in glycolysis and mitochondrial respiration. Metabolism 77, 39\u201346 (2017).","journal-title":"Metabolism"},{"key":"2714_CR484","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jdermsci.2017.12.002","volume":"89","author":"L Yang","year":"2018","unstructured":"Yang, L., Guo, W., Zhang, S. & Wang, G. Ubiquitination-proteasome system: a new player in the pathogenesis of psoriasis and clinical implications. J. Dermatol. Sci. 89, 219\u2013225 (2018).","journal-title":"J. Dermatol. Sci."},{"key":"2714_CR485","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.coi.2007.10.002","volume":"19","author":"AE Lin","year":"2007","unstructured":"Lin, A. E. & Mak, T. W. The role of E3 ligases in autoimmunity and the regulation of autoreactive T cells. Curr. Opin. Immunol. 19, 665\u2013673 (2007).","journal-title":"Curr. Opin. Immunol."},{"key":"2714_CR486","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1002\/art.21970","volume":"54","author":"M Brychcy","year":"2006","unstructured":"Brychcy, M. et al. Anti-20S proteasome autoantibodies inhibit proteasome stimulation by proteasome activator PA28. Arthritis Rheum. 54, 2175\u20132183 (2006).","journal-title":"Arthritis Rheum."},{"key":"2714_CR487","first-page":"2027","volume":"29","author":"JD Mountz","year":"2002","unstructured":"Mountz, J. D. Significance of increased circulating proteasome in autoimmune disease. J. Rheumatol. 29, 2027\u20132030 (2002).","journal-title":"J. Rheumatol."},{"key":"2714_CR488","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1136\/annrheumdis-2017-212617","volume":"77","author":"A Barrera-Vargas","year":"2018","unstructured":"Barrera-Vargas, A. et al. Differential ubiquitination in NETs regulates macrophage responses in systemic lupus erythematosus. Ann. Rheum. Dis. 77, 944\u2013950 (2018).","journal-title":"Ann. Rheum. Dis."},{"key":"2714_CR489","first-page":"1","volume":"22","author":"T Kim","year":"2020","unstructured":"Kim, T., Bae, S.-C. & Kang, C. Synergistic activation of NF-\u03baB by TNFAIP3 (A20) reduction and UBE2L3 (UBCH7) augment that synergistically elevate lupus risk. Ar. thritis Res. Ther. 22, 1\u201310 (2020).","journal-title":"thritis Res. Ther."},{"key":"2714_CR490","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clim.2016.06.003","volume":"169","author":"Y Guo","year":"2016","unstructured":"Guo, Y., Zhao, M. & Lu, Q. Transcription factor RFX1 is ubiquitinated by E3 ligase STUB1 in systemic lupus erythematosus. Clin. Immunol. 169, 1\u20137 (2016).","journal-title":"Clin. Immunol."},{"key":"2714_CR491","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1038\/s41423-018-0167-z","volume":"15","author":"Z Chong","year":"2018","unstructured":"Chong, Z. et al. E3 ligase FBXW7 aggravates TMPD-induced systemic lupus erythematosus by promoting cell apoptosis. Cell. Mol. Immunol. 15, 1057\u20131070 (2018).","journal-title":"Cell. Mol. Immunol."},{"key":"2714_CR492","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/978-0-387-70630-6_3","volume":"597","author":"PY Au","year":"2007","unstructured":"Au, P. Y. & Yeh, W. C. Physiological roles and mechanisms of signaling by TRAF2 and TRAF5. Adv. Exp. Med. Biol. 597, 32\u201347 (2007).","journal-title":"Adv. Exp. Med. Biol."},{"key":"2714_CR493","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00109-003-0422-2","volume":"81","author":"PJ Elliott","year":"2003","unstructured":"Elliott, P. J., Zollner, T. M. & Boehncke, W.-H. Proteasome inhibition: a new anti-inflammatory strategy. J. Mol. Med. 81, 235\u2013245 (2003).","journal-title":"J. Mol. Med."},{"key":"2714_CR494","doi-asserted-by":"publisher","first-page":"1433898","DOI":"10.3389\/fimmu.2024.1433898","volume":"15","author":"Q Meng","year":"2024","unstructured":"Meng, Q., Wei, K. & Shan, Y. E3 ubiquitin ligase gene BIRC3 modulates TNF-induced cell death pathways and promotes aberrant proliferation in rheumatoid arthritis fibroblast-like synoviocytes. Front. Immunol. 15, 1433898 (2024).","journal-title":"Front. Immunol."},{"key":"2714_CR495","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1038\/ng.2007.27","volume":"39","author":"RM Plenge","year":"2007","unstructured":"Plenge, R. M. et al. Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. Nat. Genet. 39, 1477\u20131482 (2007).","journal-title":"Nat. Genet."},{"key":"2714_CR496","doi-asserted-by":"publisher","first-page":"13191","DOI":"10.1074\/jbc.RA118.002649","volume":"293","author":"JK Brenke","year":"2018","unstructured":"Brenke, J. K. et al. Targeting TRAF6 E3 ligase activity with a small-molecule inhibitor combats autoimmunity. J. Biol. Chem. 293, 13191\u201313203 (2018).","journal-title":"J. Biol. Chem."},{"key":"2714_CR497","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1038\/ng.479","volume":"41","author":"S Raychaudhuri","year":"2009","unstructured":"Raychaudhuri, S. et al. Genetic variants at CD28, PRDM1 and CD2\/CD58 are associated with rheumatoid arthritis risk. Nat. Genet. 41, 1313\u20131318 (2009).","journal-title":"Nat. Genet."},{"key":"2714_CR498","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-020-01783-8","volume":"17","author":"J Ruan","year":"2020","unstructured":"Ruan, J., Schl\u00fcter, D. & Wang, X. Deubiquitinating enzymes (DUBs): DoUBle-edged swords in CNS autoimmunity. J. Neuroinflammation. 17, 1\u201311 (2020).","journal-title":"J. Neuroinflammation."},{"key":"2714_CR499","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1084\/jem.20140860","volume":"211","author":"E Naik","year":"2014","unstructured":"Naik, E. et al. Regulation of proximal T cell receptor signaling and tolerance induction by deubiquitinase Usp9X. J. Exp. Med. 211, 1947\u20131955 (2014).","journal-title":"J. Exp. Med."},{"key":"2714_CR500","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/ni.2885","volume":"15","author":"Q Zou","year":"2014","unstructured":"Zou, Q. et al. USP15 stabilizes MDM2 to mediate cancer-cell survival and inhibit antitumor T cell responses. Nat. Immunol. 15, 562\u2013570 (2014).","journal-title":"Nat. Immunol."},{"key":"2714_CR501","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1084\/jem.20062694","volume":"204","author":"WW Reiley","year":"2007","unstructured":"Reiley, W. W. et al. Deubiquitinating enzyme CYLD negatively regulates the ubiquitin-dependent kinase Tak1 and prevents abnormal T cell responses. J. Exp. Med. 204, 1475\u20131485 (2007).","journal-title":"J. Exp. Med."},{"key":"2714_CR502","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/ni.2027","volume":"12","author":"L Codarri","year":"2011","unstructured":"Codarri, L. et al. ROR\u03b3t drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat. Immunol. 12, 560\u2013567 (2011).","journal-title":"Nat. Immunol."},{"key":"2714_CR503","doi-asserted-by":"publisher","first-page":"5314541","DOI":"10.1155\/2016\/5314541","volume":"2016","author":"GRD Passos","year":"2016","unstructured":"Passos, G. R. D., Sato, D. K., Becker, J. & Fujihara, K. Th17 cells pathways in multiple sclerosis and neuromyelitis optica spectrum disorders: pathophysiological and therapeutic implications. Mediators Inflamm. 2016, 5314541 (2016).","journal-title":"Mediators Inflamm."},{"key":"2714_CR504","doi-asserted-by":"publisher","first-page":"4094","DOI":"10.4049\/jimmunol.1401451","volume":"194","author":"J Yang","year":"2015","unstructured":"Yang, J. et al. Cutting edge: ubiquitin-specific protease 4 promotes Th17 cell function under inflammation by deubiquitinating and stabilizing ROR\u03b3t. J. Immunol. 194, 4094\u20134097 (2015).","journal-title":"J. Immunol."},{"key":"2714_CR505","doi-asserted-by":"publisher","first-page":"25546","DOI":"10.1074\/jbc.M114.565291","volume":"289","author":"L Han","year":"2014","unstructured":"Han, L. et al. The E3 deubiquitinase USP17 is a positive regulator of retinoic acid-related orphan nuclear receptor \u03b3t (ROR\u03b3t) in Th17 cells. J. Biol. Chem. 289, 25546\u201325555 (2014).","journal-title":"J. Biol. Chem."},{"key":"2714_CR506","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nature13979","volume":"518","author":"S Rutz","year":"2015","unstructured":"Rutz, S. et al. Deubiquitinase DUBA is a post-translational brake on interleukin-17 production in T cells. Nature 518, 417\u2013421 (2015).","journal-title":"Nature"},{"key":"2714_CR507","doi-asserted-by":"publisher","first-page":"4439","DOI":"10.4049\/jimmunol.1303077","volume":"193","author":"KH St\u00fcrner","year":"2014","unstructured":"St\u00fcrner, K. H. et al. A multiple sclerosis\u2013associated variant of CBLB links genetic risk with type I IFN function. J. Immunol. 193, 4439\u20134447 (2014).","journal-title":"J. Immunol."},{"key":"2714_CR508","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1158\/1078-0432.CCR-13-2490","volume":"21","author":"MS Liyasova","year":"2015","unstructured":"Liyasova, M. S., Ma, K. & Lipkowitz, S. Molecular pathways: Cbl proteins in tumorigenesis and antitumor immunity\u2014opportunities for cancer treatment. Clin. Cancer Res. 21, 1789\u20131794 (2015).","journal-title":"Clin. Cancer Res."},{"key":"2714_CR509","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.3390\/ijms23052746","volume":"23","author":"X Luo","year":"2022","unstructured":"Luo, X. et al. Spliced or unspliced, that is the question: the biological roles of XBP1 isoforms in pathophysiology. Int. J. Mol. Sci. 23, 2746 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"2714_CR510","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/MAJ.0000000000000328","volume":"348","author":"Q Cheng","year":"2014","unstructured":"Cheng, Q. et al. Deficiency of IRE1 and PERK signal pathways in systemic lupus erythematosus. Am. J. Med. Sci. 348, 465\u2013473 (2014).","journal-title":"Am. J. Med. Sci."},{"key":"2714_CR511","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/embor.2008.37","volume":"9","author":"B Gao","year":"2008","unstructured":"Gao, B. et al. Synoviolin promotes IRE1 ubiquitination and degradation in synovial fibroblasts from mice with collagen-induced arthritis. EMBO Rep. 9, 480\u2013485 (2008).","journal-title":"EMBO Rep."},{"key":"2714_CR512","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3346\/jkms.2014.29.1.2","volume":"29","author":"Y-J Park","year":"2014","unstructured":"Park, Y.-J., Yoo, S.-A. & Kim, W.-U. Role of endoplasmic reticulum stress in rheumatoid arthritis pathogenesis. J. Korean Med. Sci. 29, 2\u201311 (2014).","journal-title":"J. Korean Med. Sci."},{"key":"2714_CR513","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1038\/emboj.2013.183","volume":"32","author":"Q Qiu","year":"2013","unstructured":"Qiu, Q. et al. Toll-like receptor-mediated IRE1\u03b1 activation as a therapeutic target for inflammatory arthritis. EMBO J. 32, 2477\u20132490 (2013).","journal-title":"EMBO J."},{"key":"2714_CR514","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-017-1386-x","volume":"19","author":"PA Kabala","year":"2017","unstructured":"Kabala, P. A. et al. Endoplasmic reticulum stress cooperates with Toll-like receptor ligation in driving activation of rheumatoid arthritis fibroblast-like synoviocytes. Arthritis Res. Ther. 19, 1\u201311 (2017).","journal-title":"Arthritis Res. Ther."},{"key":"2714_CR515","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1177\/1352458511399114","volume":"17","author":"P Cunnea","year":"2011","unstructured":"Cunnea, P. et al. Expression profiles of endoplasmic reticulum stress-related molecules in demyelinating lesions and multiple sclerosis. Mult. Scler. 17, 808\u2013818 (2011).","journal-title":"Mult. Scler."},{"key":"2714_CR516","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2051-5960-1-37","volume":"1","author":"M N\u00ed Fhlathartaigh","year":"2013","unstructured":"N\u00ed Fhlathartaigh, M. et al. Calreticulin and other components of endoplasmic reticulum stress in rat and human inflammatory demyelination. Acta Neuropathol. Commun. 1, 1\u201315 (2013).","journal-title":"Acta Neuropathol. Commun."},{"key":"2714_CR517","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1172\/JCI29571","volume":"117","author":"W Lin","year":"2007","unstructured":"Lin, W. et al. The integrated stress response prevents demyelination by protecting oligodendrocytes against immune-mediated damage. J. Clin. Invest. 117, 448\u2013456 (2007).","journal-title":"J. Clin. Invest."},{"key":"2714_CR518","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1093\/brain\/awl044","volume":"129","author":"W Lin","year":"2006","unstructured":"Lin, W. et al. Interferon-\u03b3 inhibits central nervous system remyelination through a process modulated by endoplasmic reticulum stress. Brain 129, 1306\u20131318 (2006).","journal-title":"Brain"},{"key":"2714_CR519","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3389\/fnins.2015.00264","volume":"9","author":"S Stone","year":"2015","unstructured":"Stone, S. & Lin, W. The unfolded protein response in multiple sclerosis. Front. Neurosci. 9, 264 (2015).","journal-title":"Front. Neurosci."},{"key":"2714_CR520","doi-asserted-by":"crossref","unstructured":"Hong, L.-J. et al. The HSP90 inhibitor, 17-AAG, influences the activation and proliferation of T lymphocytes via AKT\/GSK3\u03b2 signaling in MRL\/lpr mice. Drug Des. Devel. Ther. 14, 4605\u20134612 (2020).","DOI":"10.2147\/DDDT.S269725"},{"key":"2714_CR521","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s12192-016-0670-z","volume":"21","author":"S Tukaj","year":"2016","unstructured":"Tukaj, S. & Wegrzyn, G. Anti-Hsp90 therapy in autoimmune and inflammatory diseases: a review of preclinical studies. Cell Stress Chaperones 21, 213\u2013218 (2016).","journal-title":"Cell Stress Chaperones"},{"key":"2714_CR522","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/cmi.2012.5","volume":"9","author":"SK Shimp","year":"2012","unstructured":"Shimp, S. K. et al. Heat shock protein 90 inhibition by 17-DMAG lessens disease in the MRL\/lpr mouse model of systemic lupus erythematosus. Cell. Mol. Immunol. 9, 255\u2013266 (2012).","journal-title":"Cell. Mol. Immunol."},{"key":"2714_CR523","doi-asserted-by":"crossref","unstructured":"Wang, W. et al. Acacetin alleviates rheumatoid arthritis by targeting HSP90 ATPase domain to promote COX-2 degradation. Phytomedicine, 135, 156171 (2024).","DOI":"10.1016\/j.phymed.2024.156171"},{"key":"2714_CR524","doi-asserted-by":"publisher","first-page":"1454018","DOI":"10.3389\/fimmu.2024.1454018","volume":"15","author":"K Sitko","year":"2024","unstructured":"Sitko, K., Mantej, J., Bednarek, M. & Tukaj, S. Detection of autoantibodies to heat shock protein 70 in the saliva and urine of normal individuals. Front. Immunol. 15, 1454018 (2024).","journal-title":"Front. Immunol."},{"key":"2714_CR525","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-020-02246-4","volume":"22","author":"A Liu","year":"2020","unstructured":"Liu, A. et al. DNA vaccine encoding heat shock protein 90 protects from murine lupus. Arthritis Res. Ther. 22, 1\u20138 (2020).","journal-title":"Arthritis Res. Ther."},{"key":"2714_CR526","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1002\/art.41202","volume":"72","author":"A Liu","year":"2020","unstructured":"Liu, A. et al. DNA vaccination with Hsp70 protects against systemic lupus erythematosus in (NZB\u00d7 NZW) F1 mice. Arthritis Rheumatol. 72, 997\u20131002 (2020).","journal-title":"Arthritis Rheumatol."},{"key":"2714_CR527","doi-asserted-by":"publisher","first-page":"e12476","DOI":"10.15252\/emmm.202012476","volume":"12","author":"EL Nirk","year":"2020","unstructured":"Nirk, E. L., Reggiori, F. & Mauthe, M. Hydroxychloroquine in rheumatic autoimmune disorders and beyond. EMBO Mol. Med. 12, e12476 (2020).","journal-title":"EMBO Mol. Med."},{"key":"2714_CR528","doi-asserted-by":"publisher","first-page":"1759720X2110730","DOI":"10.1177\/1759720X211073001","volume":"14","author":"A Dima","year":"2022","unstructured":"Dima, A. et al. Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge. Ther. Adv. Musculoskelet. Dis. 14, 1759720X211073001 (2022).","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"2714_CR529","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.cell.2011.08.037","volume":"147","author":"J Liu","year":"2011","unstructured":"Liu, J. et al. Beclin1 controls the levels of p53 by regulating the deubiquitination activity of USP10 and USP13. Cell 147, 223\u2013234 (2011).","journal-title":"Cell"},{"key":"2714_CR530","doi-asserted-by":"publisher","first-page":"e2498","DOI":"10.1038\/cddis.2016.376","volume":"7","author":"S Dai","year":"2016","unstructured":"Dai, S. et al. Systemic application of 3-methyladenine markedly inhibited atherosclerotic lesion in ApoE\u2212\/\u2212 mice by modulating autophagy, foam cell formation and immune-negative molecules. Cell Death Dis. 7, e2498 (2016).","journal-title":"Cell Death Dis."},{"key":"2714_CR531","doi-asserted-by":"crossref","unstructured":"Zhang, S. et al. Rapamycin suppresses rheumatoid arthritis fibroblast synovial cell proliferation and induces apoptosis via the AKT\/mTORC1 pathway. Rheumatol. Autoimmun. 4, 156-164 (2024).","DOI":"10.1002\/rai2.12120"},{"key":"2714_CR532","doi-asserted-by":"publisher","first-page":"1446836","DOI":"10.3389\/fphys.2024.1446836","volume":"15","author":"H Kim","year":"2024","unstructured":"Kim, H. & Massett, M. P. Beneficial effects of rapamycin on endothelial function in systemic lupus erythematosus. Front. Physiol. 15, 1446836 (2024).","journal-title":"Front. Physiol."},{"key":"2714_CR533","doi-asserted-by":"crossref","unstructured":"Baeten, P. et al. Rapamycin rescues loss of function in blood-brain barrier\u2013interacting Tregs. JCI Insight. 9, e167457 (2024).","DOI":"10.1172\/jci.insight.167457"},{"key":"2714_CR534","doi-asserted-by":"publisher","first-page":"5545","DOI":"10.2147\/JIR.S436147","volume":"16","author":"H Lin","year":"2023","unstructured":"Lin, H., Ao, H., Guo, G. & Liu, M. The role and mechanism of metformin in inflammatory diseases. J. Inflamm. Res 16, 5545\u20135564 (2023).","journal-title":"J. Inflamm. Res"},{"key":"2714_CR535","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.3389\/fimmu.2018.01512","volume":"9","author":"H Yin","year":"2018","unstructured":"Yin, H. et al. The therapeutic and pathogenic role of autophagy in autoimmune diseases. Front. Immunol. 9, 1512 (2018).","journal-title":"Front. Immunol."},{"key":"2714_CR536","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.4049\/jimmunol.1403088","volume":"198","author":"S-Y Lee","year":"2017","unstructured":"Lee, S.-Y. et al. Metformin suppresses systemic autoimmunity in Roquinsan\/san mice through inhibiting B cell differentiation into plasma cells via regulation of AMPK\/mTOR\/STAT3. J. Immunol. 198, 2661\u20132670 (2017).","journal-title":"J. Immunol."},{"key":"2714_CR537","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2547-4","volume":"11","author":"Y Tian","year":"2020","unstructured":"Tian, Y. et al. Nestin protects podocyte from injury in lupus nephritis by mitophagy and oxidative stress. Cell Death Dis. 11, 319 (2020).","journal-title":"Cell Death Dis."},{"key":"2714_CR538","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.kint.2023.12.017","volume":"105","author":"H Wang","year":"2024","unstructured":"Wang, H. et al. Novel mitophagy inducer alleviates lupus nephritis by reducing myeloid cell activation and autoantigen presentation. Kidney Int. 105, 759\u2013774 (2024).","journal-title":"Kidney Int."},{"key":"2714_CR539","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1681\/ASN.2011010045","volume":"22","author":"R Allam","year":"2011","unstructured":"Allam, R. et al. Mdm2 promotes systemic lupus erythematosus and lupus nephritis. J. Am. Soc. Nephrol. 22, 2016\u20132027 (2011).","journal-title":"J. Am. Soc. Nephrol."},{"key":"2714_CR540","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1002\/art.33333","volume":"64","author":"HT Ichikawa","year":"2012","unstructured":"Ichikawa, H. T. et al. Beneficial effect of novel proteasome inhibitors in murine lupus via dual inhibition of type I interferon and autoantibody-secreting cells. Arthritis Rheum. 64, 493\u2013503 (2012).","journal-title":"Arthritis Rheum."},{"key":"2714_CR541","doi-asserted-by":"publisher","first-page":"A15","DOI":"10.1136\/annrheumdis-2011-201230.34","volume":"71","author":"F Hiepe","year":"2012","unstructured":"Hiepe, F. et al. Refractory SLE patients respond to the proteasome inhibitor bortezomib. Ann. Rheum. Dis. 71, A15\u2013A16 (2012).","journal-title":"Ann. Rheum. Dis."},{"key":"2714_CR542","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1002\/art.41883","volume":"73","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y. et al. Inositol-requiring enzyme 1\u03b1-mediated synthesis of monounsaturated fatty acids as a driver of B cell differentiation and lupus-like autoimmune disease. Arthritis Rheumatol. 73, 2314\u20132326 (2021).","journal-title":"Arthritis Rheumatol."},{"key":"2714_CR543","doi-asserted-by":"crossref","unstructured":"Sule, G. et al. Endoplasmic reticulum stress sensor IRE1\u03b1 propels neutrophil hyperactivity in lupus. J. Clin. Invest. 131, e137866 (2021).","DOI":"10.1172\/JCI137866"},{"key":"2714_CR544","doi-asserted-by":"publisher","first-page":"7625817","DOI":"10.1155\/2023\/7625817","volume":"2023","author":"H-Y Li","year":"2023","unstructured":"Li, H.-Y. et al. Endoplasmic reticulum stress in systemic lupus erythematosus and lupus nephritis: potential therapeutic target. J. Immunol. Res. 2023, 7625817 (2023).","journal-title":"J. Immunol. Res."},{"key":"2714_CR545","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.cellsig.2015.01.010","volume":"27","author":"K Hamamura","year":"2015","unstructured":"Hamamura, K. et al. Salubrinal acts as a Dusp2 inhibitor and suppresses inflammation in anti-collagen antibody-induced arthritis. Cell. Signal. 27, 828\u2013835 (2015).","journal-title":"Cell. Signal."},{"key":"2714_CR546","doi-asserted-by":"publisher","first-page":"F763","DOI":"10.1152\/ajprenal.00225.2016","volume":"311","author":"P Zheng","year":"2016","unstructured":"Zheng, P. et al. 4-PBA improves lithium-induced nephrogenic diabetes insipidus by attenuating ER stress. Am. J. Physiol. Ren. Physiol. 311, F763\u2013F776 (2016).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"2714_CR547","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1042\/CS20180562","volume":"133","author":"ML Bonnemaison","year":"2019","unstructured":"Bonnemaison, M. L., Marks-Nelson, E. S. & Boesen, E. I. Sodium 4-phenylbutyrate treatment protects against renal injury in NZBWF1 mice. Clin. Sci. 133, 167\u2013180 (2019).","journal-title":"Clin. Sci."},{"key":"2714_CR548","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nrm2941","volume":"11","author":"HH Kampinga","year":"2010","unstructured":"Kampinga, H. H. & Craig, E. A. The HSP70 chaperone machinery: J proteins as drivers of functional specificity. Nat. Rev. Mol. Cell Biol. 11, 579\u2013592 (2010).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2714_CR549","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.tcb.2018.10.004","volume":"29","author":"TM Luengo","year":"2018","unstructured":"Luengo, T. M., Mayer, M. P. & R\u00fcdiger, S. G. D. The Hsp70\u2013Hsp90 chaperone cascade in protein folding. Trends Cell Biol. 29, 164\u2013177 (2018).","journal-title":"Trends Cell Biol."},{"key":"2714_CR550","doi-asserted-by":"publisher","first-page":"R170","DOI":"10.1016\/j.cub.2018.01.004","volume":"28","author":"S Pickles","year":"2018","unstructured":"Pickles, S., Vigi\u00e9, P. & Youle, R. J. Mitophagy and quality control mechanisms in mitochondrial maintenance. Curr. Biol. 28, R170\u2013R185 (2018).","journal-title":"Curr. Biol."},{"key":"2714_CR551","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114891","volume":"197","author":"H Liu","year":"2022","unstructured":"Liu, H. et al. The role of FUNDC1 in mitophagy, mitochondrial dynamics and human diseases. Biochem. Pharmacol. 197, 114891 (2022).","journal-title":"Biochem. Pharmacol."},{"key":"2714_CR552","first-page":"32","volume":"11","author":"BH Liu","year":"2024","unstructured":"Liu, B. H. et al. Mitochondrial quality control in human health and disease. Mil. Med. Res. 11, 32 (2024).","journal-title":"Mil. Med. Res."},{"key":"2714_CR553","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.tcb.2013.12.003","volume":"24","author":"G Kleiger","year":"2014","unstructured":"Kleiger, G. & Mayor, T. Perilous journey: a tour of the ubiquitin\u2013proteasome system. Trends Cell Biol. 24, 352\u2013359 (2014).","journal-title":"Trends Cell Biol."},{"key":"2714_CR554","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1007\/s10238-023-01075-4","volume":"23","author":"P Huang","year":"2023","unstructured":"Huang, P., Wang, Y., Zhang, P. & Li, Q. Ubiquitin-specific peptidase 1: assessing its role in cancer therapy. Clin. Exp. Med. 23, 2953\u20132966 (2023).","journal-title":"Clin. Exp. Med."},{"key":"2714_CR555","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-022-01364-6","volume":"20","author":"C Hou","year":"2022","unstructured":"Hou, C. et al. Systematic prediction of degrons and E3 ubiquitin ligase binding via deep learning. BMC Biol. 20, 162 (2022).","journal-title":"BMC Biol."},{"key":"2714_CR556","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.molcel.2017.06.017","volume":"69","author":"C Hetz","year":"2018","unstructured":"Hetz, C. & Papa, F. R. The unfolded protein response and cell fate control. Mol. Cell. 69, 169\u2013181 (2018).","journal-title":"Mol. Cell."},{"key":"2714_CR557","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/0968-0004(90)90019-8","volume":"15","author":"JF Dice","year":"1990","unstructured":"Dice, J. F. Peptide sequences that target cytosolic proteins for lysosomal proteolysis. Trends Biochem. Sci. 15, 305\u2013309 (1990).","journal-title":"Trends Biochem. Sci."},{"key":"2714_CR558","doi-asserted-by":"publisher","first-page":"736905","DOI":"10.1155\/2012\/736905","volume":"2012","author":"T Lamark","year":"2012","unstructured":"Lamark, T. & Johansen, T. Aggrephagy: selective disposal of protein aggregates by macroautophagy. Int. J. Cell Biol. 2012, 736905 (2012).","journal-title":"Int. J. Cell Biol."},{"key":"2714_CR559","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1097\/01.cad.0000136876.11928.be","volume":"15","author":"J Beliakoff","year":"2004","unstructured":"Beliakoff, J. & Whitesell, L. Hsp90: an emerging target for breast cancer therapy. Anticancer Drugs 15, 651\u2013662 (2004).","journal-title":"Anticancer Drugs"}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02714-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02714-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02714-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T23:02:44Z","timestamp":1780959764000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02714-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":559,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2714"],"URL":"https:\/\/doi.org\/10.1038\/s41392-026-02714-4","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,9]]},"assertion":[{"value":"24 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"224"}}